BACKGROUND: Severe trauma continues to represent a global public health issue and mortality and morbidity in trauma patients remains substantial. A number of initiatives have aimed to provide guidance on the management of trauma patients. This document focuses on the management of major bleeding and coagulopathy following trauma and encourages adaptation of the guiding principles to each local situation and implementation within each institution. METHODS: The pan-European, multidisciplinary Task Force for Advanced Bleeding Care in Trauma was founded in 2004 and included representatives of six relevant European professional societies. The group used a structured, evidence-based consensus approach to address scientific queries that served as the basis for each recommendation and supporting rationale. Expert opinion and current clinical practice were also considered, particularly in areas in which randomised clinical trials have not or cannot be performed. Existing recommendations were reconsidered and revised based on new scientific evidence and observed shifts in clinical practice; new recommendations were formulated to reflect current clinical concerns and areas in which new research data have been generated. This guideline represents the fourth edition of a document first published in 2007 and updated in 2010 and 2013. RESULTS: The guideline now recommends that patients be transferred directly to an appropriate trauma treatment centre and encourages use of a restricted volume replacement strategy during initial resuscitation. Best-practice use of blood products during further resuscitation continues to evolve and should be guided by a goal-directed strategy. The identification and management of patients pre-treated with anticoagulant agents continues to pose a real challenge, despite accumulating experience and awareness. The present guideline should be viewed as an educational aid to improve and standardise the care of the bleeding trauma patients across Europe and beyond. This document may also serve as a basis for local implementation. Furthermore, local quality and safety management systems need to be established to specifically assess key measures of bleeding control and outcome. CONCLUSIONS: A multidisciplinary approach and adherence to evidence-based guidance are key to improving patient outcomes. The implementation of locally adapted treatment algorithms should strive to achieve measureable improvements in patient outcome.

Department of Anaesthesia and Intensive Care Hôpitaux Universitaires Paris Sud University of Paris XI Faculté de Médecine Paris Sud 78 rue du Général Leclerc 94275 Le Kremlin Bicêtre Cedex France

Department of Anaesthesia Pain Management and Perioperative Medicine Dalhousie University Halifax QE 2 Health Sciences Centre 10 West Victoria 1276 South Park St Halifax NS B3H 2Y9 Canada

Department of Anaesthesiology and Intensive Care Charles University Prague Faculty of Medicine in Hradec Kralove Sokolska 581 50005 Hradec Kralove Czech Republic

Department of Anaesthesiology Perioperative Medicine and Intensive Care J E Purkinje University Masaryk Hospital Usti nad Labem Socialni pece 3316 12A 40113 Usti nad Labem Czech Republic

Department of Anaesthesiology University Hospital Aachen RWTH Aachen University Pauwelsstrasse 30 52074 Aachen Germany

Department of Cardiac Anaesthesia and Intensive Care C C Iliescu Emergency Institute of Cardiovascular Diseases Sos Fundeni 256 258 022328 Bucharest Romania

Department of Intensive Care Erasme University Hospital Université Libre de Bruxelles Route de Lennik 808 1070 Brussels Belgium

Department of Research and Development Charles University Prague Faculty of Medicine in Hradec Kralove Sokolska 581 50005 Hradec Kralove Czech Republic

Department of Surgery and Trauma Karolinska University Hospital 171 76 Solna Sweden

Department of Trauma and Orthopaedic Surgery Witten Herdecke University Cologne Merheim Medical Centre Ostmerheimer Strasse 200 51109 Cologne Germany

Department of Traumatology General and Teaching Hospital Celje Oblakova 5 3000 Celje Slovenia

Division of Anaesthesia Intensive Care and Emergency Medicine Brest University Hospital Boulevard Tanguy Prigent 29200 Brest France

Emergency Medicine Academic Group University of Leicester University Road Leicester LE1 7RH UK

Faculty of Health School of Medicine Witten Herdecke University Ostmerheimer Strasse 200 Building 38 51109 Cologne Germany

Institute of Anaesthesiology University of Zurich and University Hospital Zurich Raemistrasse 100 8091 Zurich Switzerland

King's College Departments of Haematology Pathology and Lupus Guy's and St Thomas' NHS Foundation Trust Westminster Bridge Road London SE1 7EH UK

Ludwig Boltzmann Institute for Experimental and Clinical Traumatology Lorenz Boehler Trauma Centre Donaueschingenstrasse 13 1200 Vienna Austria

Servicio de Medicina Intensiva Complejo Hospitalario Universitario de Granada ctra de Jaén s n 18013 Granada Spain

Shock and Trauma Centre S Camillo Hospital Viale Gianicolense 87 00152 Rome Italy

See more in PubMed

World Health Organization. Injuries and violence: the facts; http://whqlibdoc.who.int/publications/2010/9789241599375_eng.pdf; 2010. Accessed 30 Jan 2015.

GBD 2013 Mortality and Causes of Death Collaborators Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;385(9963):117–171. doi: 10.1016/S0140-6736(14)61682-2. PubMed DOI PMC

Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet. 1997;349(9064):1498–1504. doi: 10.1016/S0140-6736(96)07492-2. PubMed DOI

World Health Organization W. The global burden of disease: 2004 update; http://www.who.int/healthinfo/global_burden_disease/GBD_report_2004update_full.pdf?ua=1; 2008.  Accessed 30 Jan 2015.

World Health Organization. Cause-specific mortality and morbidity. 2009. http://www.who.int/whosis/whostat/EN_WHS09_Table2.pdf. Accessed 30 Jan 2015.

Cothren CC, Moore EE, Hedegaard HB, Meng K. Epidemiology of urban trauma deaths: a comprehensive reassessment 10 years later. World J Surg. 2007;31(7):1507–1511. doi: 10.1007/s00268-007-9087-2. PubMed DOI

Campbell HE, Stokes EA, Bargo DN, Curry N, Lecky FE, Edwards A, et al. Quantifying the healthcare costs of treating severely bleeding major trauma patients: a national study for England. Crit Care. 2015;19(1):276. doi: 10.1186/s13054-015-0987-5. PubMed DOI PMC

Frith D, Goslings JC, Gaarder C, Maegele M, Cohen MJ, Allard S, et al. Definition and drivers of acute traumatic coagulopathy: clinical and experimental investigations. J Thromb Haemost. 2010;8(9):1919–1925. doi: 10.1111/j.1538-7836.2010.03945.x. PubMed DOI

Maegele M, Lefering R, Yucel N, Tjardes T, Rixen D, Paffrath T, et al. Early coagulopathy in multiple injury: an analysis from the German Trauma Registry on 8724 patients. Injury. 2007;38(3):298–304. doi: 10.1016/j.injury.2006.10.003. PubMed DOI

Brohi K, Singh J, Heron M, Coats T. Acute traumatic coagulopathy. J Trauma. 2003;54(6):1127–1130. doi: 10.1097/01.TA.0000069184.82147.06. PubMed DOI

MacLeod JB, Lynn M, McKenney MG, Cohn SM, Murtha M. Early coagulopathy predicts mortality in trauma. J Trauma. 2003;55(1):39–44. doi: 10.1097/01.TA.0000075338.21177.EF. PubMed DOI

Schöchl H, Nienaber U, Maegele M, Hochleitner G, Primavesi F, Steitz B, et al. Transfusion in trauma: thromboelastometry-guided coagulation factor concentrate-based therapy versus standard fresh frozen plasma-based therapy. Crit Care. 2011;15(2):R83. doi: 10.1186/cc10078. PubMed DOI PMC

Schöchl H, Frietsch T, Pavelka M, Jambor C. Hyperfibrinolysis after major trauma: differential diagnosis of lysis patterns and prognostic value of thrombelastometry. J Trauma. 2009;67(1):125–131. doi: 10.1097/TA.0b013e31818b2483. PubMed DOI

Maegele M, Schochl H, Cohen MJ. An update on the coagulopathy of trauma. Shock. 2014;41(Suppl 1):21–25. doi: 10.1097/SHK.0000000000000088. PubMed DOI

Khan S, Davenport R, Raza I, Glasgow S, De’Ath HD, Johansson PI, et al. Damage control resuscitation using blood component therapy in standard doses has a limited effect on coagulopathy during trauma hemorrhage. Intensive Care Med. 2015;41(2):239–247. doi: 10.1007/s00134-014-3584-1. PubMed DOI

Moore EE, Knudson MM, Jurkovich GJ, Fildes JJ, Meredith JW. Emergency traumatologist or trauma and acute care surgeon: decision time. J Am Coll Surg. 2009;209(3):394–395. doi: 10.1016/j.jamcollsurg.2009.06.003. PubMed DOI

Cap A, Hunt BJ. The pathogenesis of traumatic coagulopathy. Anaesthesia. 2015;70 Suppl 1:96–101. doi: 10.1111/anae.12914. PubMed DOI

Hess JR, Brohi K, Dutton RP, Hauser CJ, Holcomb JB, Kluger Y, et al. The coagulopathy of trauma: a review of mechanisms. J Trauma. 2008;65(4):748–754. doi: 10.1097/TA.0b013e3181877a9c. PubMed DOI

Brohi K. Trauma induced coagulopathy. J R Army Med Corps. 2009;155(4):320–322. doi: 10.1136/jramc-155-04-15. PubMed DOI

Johansson PI, Sorensen AM, Perner A, Welling KL, Wanscher M, Larsen CF, et al. Disseminated intravascular coagulation or acute coagulopathy of trauma shock early after trauma? An observational study. Crit Care. 2011;15(6):R272. doi: 10.1186/cc10553. PubMed DOI PMC

Frith D, Brohi K. The pathophysiology of trauma-induced coagulopathy. Curr Opin Crit Care. 2012;18(6):631–636. doi: 10.1097/MCC.0b013e3283599ab9. PubMed DOI

Hagemo JS, Christiaans SC, Stanworth SJ, Brohi K, Johansson PI, Goslings JC, et al. Detection of acute traumatic coagulopathy and massive transfusion requirements by means of rotational thromboelastometry: an international prospective validation study. Crit Care. 2015;19:97. doi: 10.1186/s13054-015-0823-y. PubMed DOI PMC

Hagemo JS, Stanworth S, Juffermans NP, Brohi K, Cohen M, Johansson PI, et al. Prevalence, predictors and outcome of hypofibrinogenaemia in trauma: a multicentre observational study. Crit Care. 2014;18(2):R52. doi: 10.1186/cc13798. PubMed DOI PMC

Brohi K, Cohen MJ, Ganter MT, Schultz MJ, Levi M, Mackersie RC, et al. Acute coagulopathy of trauma: hypoperfusion induces systemic anticoagulation and hyperfibrinolysis. J Trauma. 2008;64(5):1211–1217. doi: 10.1097/TA.0b013e318169cd3c. PubMed DOI

Rugeri L, Levrat A, David JS, Delecroix E, Floccard B, Gros A, et al. Diagnosis of early coagulation abnormalities in trauma patients by rotation thrombelastography. J Thromb Haemost. 2007;5(2):289–295. doi: 10.1111/j.1538-7836.2007.02319.x. PubMed DOI

Hess JR, Lawson JH. The coagulopathy of trauma versus disseminated intravascular coagulation. J Trauma. 2006;60(6 Suppl):S12–S19. doi: 10.1097/01.ta.0000199545.06536.22. PubMed DOI

Spahn DR, Rossaint R. Coagulopathy and blood component transfusion in trauma. Br J Anaesth. 2005;95(2):130–139. doi: 10.1093/bja/aei169. PubMed DOI

Hussmann B, Lefering R, Waydhas C, Touma A, Kauther MD, Ruchholtz S, et al. Does increased prehospital replacement volume lead to a poor clinical course and an increased mortality? A matched-pair analysis of 1896 patients of the Trauma Registry of the German Society for Trauma Surgery who were managed by an emergency doctor at the accident site. Injury. 2013;44(5):611–617. doi: 10.1016/j.injury.2012.02.004. PubMed DOI

Frith D, Davenport R, Brohi K. Acute traumatic coagulopathy. Curr Opin Anaesthesiol. 2012;25(2):229–234. doi: 10.1097/ACO.0b013e3283509675. PubMed DOI

Spivey M, Parr MJ. Therapeutic approaches in trauma-induced coagulopathy. Minerva Anestesiol. 2005;71(6):281–289. PubMed

Engels PT, Rezende-Neto JB, Al Mahroos M, Scarpelini S, Rizoli SB, Tien HC. The natural history of trauma-related coagulopathy: implications for treatment. J Trauma. 2011;71(5 Suppl 1):S448–S455. doi: 10.1097/TA.0b013e318232e6ac. PubMed DOI

Spahn DR, Cerny V, Coats TJ, Duranteau J, Fernandez-Mondejar E, Gordini G, et al. Management of bleeding following major trauma: a European guideline. Crit Care. 2007;11(1):R17. doi: 10.1186/cc5686. PubMed DOI PMC

Rossaint R, Bouillon B, Cerny V, Coats TJ, Duranteau J, Fernandez-Mondejar E, et al. Management of bleeding following major trauma: an updated European guideline. Crit Care. 2010;14(2):R52. doi: 10.1186/cc8943. PubMed DOI PMC

Spahn DR, Bouillon B, Cerny V, Coats TJ, Duranteau J, Fernandez-Mondejar E, et al. Management of bleeding and coagulopathy following major trauma: an updated European guideline. Crit Care. 2013;17(2):R76. doi: 10.1186/cc12685. PubMed DOI PMC

Rossaint R, Bouillon B, Cerny V, Coats TJ, Duranteau J, Fernandez-Mondejar E, et al. The STOP the Bleeding Campaign. Crit Care. 2013;17(2):136. doi: 10.1186/cc12579. PubMed DOI PMC

Guyatt G, Gutterman D, Baumann MH, Addrizzo-Harris D, Hylek EM, Phillips B, et al. Grading strength of recommendations and quality of evidence in clinical guidelines: report from an American College of Chest Physicians task force. Chest. 2006;129(1):174–181. doi: 10.1378/chest.129.1.174. PubMed DOI

Jurkovich GJ, Mock C. Systematic review of trauma system effectiveness based on registry comparisons. J Trauma. 1999;47(3 Suppl):S46–S55. doi: 10.1097/00005373-199909001-00011. PubMed DOI

Mann NC, Mullins RJ, MacKenzie EJ, Jurkovich GJ, Mock CN. Systematic review of published evidence regarding trauma system effectiveness. J Trauma. 1999;47(3 Suppl):S25–S33. doi: 10.1097/00005373-199909001-00007. PubMed DOI

Celso B, Tepas J, Langland-Orban B, Pracht E, Papa L, Lottenberg L, et al. A systematic review and meta-analysis comparing outcome of severely injured patients treated in trauma centers following the establishment of trauma systems. J Trauma. 2006;60(2):371–378. doi: 10.1097/01.ta.0000197916.99629.eb. PubMed DOI

Hill AD, Fowler RA, Nathens AB. Impact of interhospital transfer on outcomes for trauma patients: a systematic review. J Trauma. 2011;71(6):1885–1900. doi: 10.1097/TA.0b013e31823ac642. PubMed DOI

Williams T, Finn J, Fatovich D, Jacobs I. Outcomes of different health care contexts for direct transport to a trauma center versus initial secondary center care: a systematic review and meta-analysis. Prehosp Emerg Care. 2013;17(4):442–457. doi: 10.3109/10903127.2013.804137. PubMed DOI

Calland JF, Ingraham AM, Martin N, Marshall GT, Schulman CI, Stapleton T, et al. Evaluation and management of geriatric trauma: an Eastern Association for the Surgery of Trauma practice management guideline. J Trauma Acute Care Surg. 2012;73(5 Suppl 4):S345–S350. doi: 10.1097/TA.0b013e318270191f. PubMed DOI

Caputo LM, Salottolo KM, Slone DS, Mains CW, Bar-Or D. The relationship between patient volume and mortality in American trauma centres: a systematic review of the evidence. Injury. 2014;45(3):478–486. doi: 10.1016/j.injury.2013.09.038. PubMed DOI

Hoyt DB, Bulger EM, Knudson MM, Morris J, Ierardi R, Sugerman HJ, et al. Death in the operating room: an analysis of a multi-center experience. J Trauma. 1994;37(3):426–432. doi: 10.1097/00005373-199409000-00016. PubMed DOI

Martin M, Oh J, Currier H, Tai N, Beekley A, Eckert M, et al. An analysis of in-hospital deaths at a modern combat support hospital. J Trauma. 2009;66(4 Suppl):S51–S60. doi: 10.1097/TA.0b013e31819d86ad. PubMed DOI

Smith W, Williams A, Agudelo J, Shannon M, Morgan S, Stahel P, et al. Early predictors of mortality in hemodynamically unstable pelvis fractures. J Orthop Trauma. 2007;21(1):31–37. doi: 10.1097/BOT.0b013e31802ea951. PubMed DOI

Hill DA, West RH, Roncal S. Outcome of patients with haemorrhagic shock: an indicator of performance in a trauma centre. J R Coll Surg Edinb. 1995;40(4):221–224. PubMed

Thoburn E, Norris P, Flores R, Goode S, Rodriguez E, Adams V, et al. System care improves trauma outcome: patient care errors dominate reduced preventable death rate. J Emerg Med. 1993;11(2):135–139. doi: 10.1016/0736-4679(93)90507-4. PubMed DOI

Lakstein D, Blumenfeld A, Sokolov T, Lin G, Bssorai R, Lynn M, et al. Tourniquets for hemorrhage control on the battlefield: a 4-year accumulated experience. J Trauma. 2003;54(5 Suppl):S221–S225. PubMed

Beekley AC, Sebesta JA, Blackbourne LH, Herbert GS, Kauvar DS, Baer DG, et al. Prehospital tourniquet use in Operation Iraqi Freedom: effect on hemorrhage control and outcomes. J Trauma. 2008;64(2 Suppl):S28–S37. doi: 10.1097/TA.0b013e318160937e. PubMed DOI

Brodie S, Hodgetts TJ, Ollerton J, McLeod J, Lambert P, Mahoney P. Tourniquet use in combat trauma: UK military experience. J R Army Med Corps. 2007;153(4):310–313. doi: 10.1136/jramc-153-04-19. PubMed DOI

Kragh JF, Jr, Walters TJ, Baer DG, Fox CJ, Wade CE, Salinas J, et al. Survival with emergency tourniquet use to stop bleeding in major limb trauma. Ann Surg. 2009;249(1):1–7. doi: 10.1097/SLA.0b013e31818842ba. PubMed DOI

Swan KG, Jr, Wright DS, Barbagiovanni SS, Swan BC, Swan KG. Tourniquets revisited. J Trauma. 2009;66(3):672–5. doi: 10.1097/TA.0b013e3181986959. PubMed DOI

Kragh JF, Jr, O’Neill ML, Walters TJ, Jones JA, Baer DG, Gershman LK, et al. Minor morbidity with emergency tourniquet use to stop bleeding in severe limb trauma: research, history, and reconciling advocates and abolitionists. Mil Med. 2011;176(7):817–823. doi: 10.7205/MILMED-D-10-00417. PubMed DOI

Kragh JF, Jr, Cooper A, Aden JK, Dubick MA, Baer DG, Wade CE, et al. Survey of trauma registry data on tourniquet use in pediatric war casualties. Pediatr Emerg Care. 2012;28(12):1361–1365. doi: 10.1097/PEC.0b013e318276c260. PubMed DOI

Dayan L, Zinmann C, Stahl S, Norman D. Complications associated with prolonged tourniquet application on the battlefield. Mil Med. 2008;173(1):63–66. doi: 10.7205/MILMED.173.1.63. PubMed DOI

Bulger EM, Snyder D, Schoelles K, Gotschall C, Dawson D, Lang E, et al. An evidence-based prehospital guideline for external hemorrhage control: American College of Surgeons Committee on Trauma. Prehosp Emerg Care. 2014;18(2):163–173. doi: 10.3109/10903127.2014.896962. PubMed DOI

Fox N, Rajani RR, Bokhari F, Chiu WC, Kerwin A, Seamon MJ, et al. Evaluation and management of penetrating lower extremity arterial trauma: an Eastern Association for the Surgery of Trauma practice management guideline. J Trauma Acute Care Surg. 2012;73(5 Suppl 4):S315–S320. doi: 10.1097/TA.0b013e31827018e4. PubMed DOI

Mayglothling J, Duane TM, Gibbs M, McCunn M, Legome E, Eastman AL, et al. Emergency tracheal intubation immediately following traumatic injury: an Eastern Association for the Surgery of Trauma practice management guideline. J Trauma Acute Care Surg. 2012;73(5 Suppl 4):S333–S340. doi: 10.1097/TA.0b013e31827018a5. PubMed DOI

Shafi S, Gentilello L. Pre-hospital endotracheal intubation and positive pressure ventilation is associated with hypotension and decreased survival in hypovolemic trauma patients: an analysis of the National Trauma Data Bank. J Trauma. 2005;59(5):1140–1145. doi: 10.1097/01.ta.0000196434.88182.77. PubMed DOI

Bukur M, Kurtovic S, Berry C, Tanios M, Margulies DR, Ley EJ, et al. Pre-hospital intubation is associated with increased mortality after traumatic brain injury. J Surg Res. 2011;170(1):e117–e121. doi: 10.1016/j.jss.2011.04.005. PubMed DOI

Bernard SA, Nguyen V, Cameron P, Masci K, Fitzgerald M, Cooper DJ, et al. Prehospital rapid sequence intubation improves functional outcome for patients with severe traumatic brain injury: a randomized controlled trial. Ann Surg. 2010;252(6):959–965. doi: 10.1097/SLA.0b013e3181efc15f. PubMed DOI

Boer C, Franschman G, Loer SA. Prehospital management of severe traumatic brain injury: concepts and ongoing controversies. Curr Opin Anaesthesiol. 2012;25(5):556–562. doi: 10.1097/ACO.0b013e328357225c. PubMed DOI

Jeremitsky E, Omert L, Dunham CM, Protetch J, Rodriguez A. Harbingers of poor outcome the day after severe brain injury: hypothermia, hypoxia, and hypoperfusion. J Trauma. 2003;54(2):312–319. doi: 10.1097/01.TA.0000037876.37236.D6. PubMed DOI

Chi JH, Knudson MM, Vassar MJ, McCarthy MC, Shapiro MB, Mallet S, et al. Prehospital hypoxia affects outcome in patients with traumatic brain injury: a prospective multicenter study. J Trauma. 2006;61(5):1134–1141. doi: 10.1097/01.ta.0000196644.64653.d8. PubMed DOI

Damiani E, Adrario E, Girardis M, Romano R, Pelaia P, Singer M, et al. Arterial hyperoxia and mortality in critically ill patients: a systematic review and meta-analysis. Crit Care. 2014;18(6):711. doi: 10.1186/s13054-014-0711-x. PubMed DOI PMC

Rincon F, Kang J, Vibbert M, Urtecho J, Athar MK, Jallo J. Significance of arterial hyperoxia and relationship with case fatality in traumatic brain injury: a multicentre cohort study. J Neurol Neurosurg Psychiatry. 2014;85(7):799–805. doi: 10.1136/jnnp-2013-305505. PubMed DOI

Brenner M, Stein D, Hu P, Kufera J, Wooford M, Scalea T. Association between early hyperoxia and worse outcomes after traumatic brain injury. Arch Surg. 2012;147(11):1042–1046. doi: 10.1001/archsurg.2012.1560. PubMed DOI

Aufderheide TP, Sigurdsson G, Pirrallo RG, Yannopoulos D, McKnite S, von Briesen C, et al. Hyperventilation-induced hypotension during cardiopulmonary resuscitation. Circulation. 2004;109(16):1960–1965. doi: 10.1161/01.CIR.0000126594.79136.61. PubMed DOI

Davis DP, Hoyt DB, Ochs M, Fortlage D, Holbrook T, Marshall LK, et al. The effect of paramedic rapid sequence intubation on outcome in patients with severe traumatic brain injury. J Trauma. 2003;54(3):444–453. doi: 10.1097/01.TA.0000053396.02126.CD. PubMed DOI

Manley GT, Hemphill JC, Morabito D, Derugin N, Erickson V, Pitts LH, et al. Cerebral oxygenation during hemorrhagic shock: perils of hyperventilation and the therapeutic potential of hypoventilation. J Trauma. 2000;48(6):1025–1032. doi: 10.1097/00005373-200006000-00005. PubMed DOI

Blomgren K, Zhu C, Hallin U, Hagberg H. Mitochondria and ischemic reperfusion damage in the adult and in the developing brain. Biochem Biophys Res Commun. 2003;304(3):551–559. doi: 10.1016/S0006-291X(03)00628-4. PubMed DOI

Davis DP, Idris AH, Sise MJ, Kennedy F, Eastman AB, Velky T, et al. Early ventilation and outcome in patients with moderate to severe traumatic brain injury. Crit Care Med. 2006;34(4):1202–1208. doi: 10.1097/01.CCM.0000208359.74623.1C. PubMed DOI

Davis DP. Early ventilation in traumatic brain injury. Resuscitation. 2008;76(3):333–340. doi: 10.1016/j.resuscitation.2007.08.004. PubMed DOI

Curley G, Kavanagh BP, Laffey JG. Hypocapnia and the injured brain: more harm than benefit. Crit Care Med. 2010;38(5):1348–1359. doi: 10.1097/CCM.0b013e3181d8cf2b. PubMed DOI

Stevens RD, Shoykhet M, Cadena R. Emergency neurological life support: intracranial hypertension and herniation. Neurocrit Care. 2015;23(Suppl 2):76–82. doi: 10.1007/s12028-015-0168-z. PubMed DOI PMC

The Acute Respiratory Distress Syndrome Network: Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000;342(18):1301-8. PubMed

Wolthuis EK, Choi G, Dessing MC, Bresser P, Lutter R, Dzoljic M, et al. Mechanical ventilation with lower tidal volumes and positive end-expiratory pressure prevents pulmonary inflammation in patients without preexisting lung injury. Anesthesiology. 2008;108(1):46–54. doi: 10.1097/01.anes.0000296068.80921.10. PubMed DOI

Frank M, Schmucker U, Stengel D, Fischer L, Lange J, Grossjohann R, et al. Proper estimation of blood loss on scene of trauma: tool or tale? J Trauma. 2010;69(5):1191–1195. doi: 10.1097/TA.0b013e3181c452e7. PubMed DOI

Liu CC, Wang CY, Shih HC, Wen YS, Wu JJ, Huang CI, et al. Prognostic factors for mortality following falls from height. Injury. 2009;40(6):595–597. doi: 10.1016/j.injury.2008.11.014. PubMed DOI

Cinelli SM, Brady P, Rennie CP, Tuluca C, Hall TS. Comparative results of trauma scoring systems in fatal outcomes. Conn Med. 2009;73(5):261–265. PubMed

Moore L, Lavoie A, Turgeon AF, Abdous B, Le Sage N, Emond M, et al. The trauma risk adjustment model: a new model for evaluating trauma care. Ann Surg. 2009;249(6):1040–1046. doi: 10.1097/SLA.0b013e3181a6cd97. PubMed DOI

Narci A, Solak O, Turhan-Haktanir N, Aycicek A, Demir Y, Ela Y, et al. The prognostic importance of trauma scoring systems in pediatric patients. Pediatr Surg Int. 2009;25(1):25–30. doi: 10.1007/s00383-008-2287-5. PubMed DOI

American College of Surgeons Committee on Trauma. ATLS® Student Manual 9th Edition. Chicago, IL: American College of Surgeons; 2012.

Lawton LD, Roncal S, Leonard E, Stack A, Dinh MM, Byrne CM, et al. The utility of Advanced Trauma Life Support (ATLS) clinical shock grading in assessment of trauma. Emerg Med J. 2014;31(5):384–389. doi: 10.1136/emermed-2012-201813. PubMed DOI

Mutschler M, Paffrath T, Wolfl C, Probst C, Nienaber U, Schipper IB, et al. The ATLS((R)) classification of hypovolaemic shock: a well established teaching tool on the edge? Injury. 2014;45(Suppl 3):S35–S38. doi: 10.1016/j.injury.2014.08.015. PubMed DOI

Mutschler M, Nienaber U, Brockamp T, Wafaisade A, Wyen H, Peiniger S, et al. A critical reappraisal of the ATLS classification of hypovolaemic shock: does it really reflect clinical reality? Resuscitation. 2013;84(3):309–313. doi: 10.1016/j.resuscitation.2012.07.012. PubMed DOI

Guly HR, Bouamra O, Spiers M, Dark P, Coats T, Lecky FE. Vital signs and estimated blood loss in patients with major trauma: testing the validity of the ATLS classification of hypovolaemic shock. Resuscitation. 2011;82(5):556–559. doi: 10.1016/j.resuscitation.2011.01.013. PubMed DOI

Olaussen A, Blackburn T, Mitra B, Fitzgerald M. Review article: shock index for prediction of critical bleeding post-trauma: a systematic review. Emerg Med Australas. 2014;26(3):223–228. doi: 10.1111/1742-6723.12232. PubMed DOI

DeMuro JP, Simmons S, Jax J, Gianelli SM. Application of the Shock Index to the prediction of need for hemostasis intervention. Am J Emerg Med. 2013;31(8):1260–1263. doi: 10.1016/j.ajem.2013.05.027. PubMed DOI

Paladino L, Subramanian RA, Nabors S, Sinert R. The utility of shock index in differentiating major from minor injury. Eur J Emerg Med. 2011;18(2):94–98. doi: 10.1097/MEJ.0b013e32833f212b. PubMed DOI

Maegele M. Frequency, risk stratification and therapeutic management of acute post-traumatic coagulopathy. Vox Sang. 2009;97(1):39–49. doi: 10.1111/j.1423-0410.2009.01179.x. PubMed DOI

Maegele M, Paffrath T, Bouillon B. Acute traumatic coagulopathy in severe injury: incidence, risk stratification, and treatment options. Dtsch Arztebl Int. 2011;108(49):827–835. PubMed PMC

Jackson MR, Olson DW, Beckett WC, Jr, Olsen SB, Robertson FM. Abdominal vascular trauma: a review of 106 injuries. Am Surg. 1992;58(10):622–626. PubMed

Johnson JW, Gracias VH, Schwab CW, Reilly PM, Kauder DR, Shapiro MB, et al. Evolution in damage control for exsanguinating penetrating abdominal injury. J Trauma. 2001;51(2):261–269. doi: 10.1097/00005373-200108000-00007. PubMed DOI

Billy LJ, Amato JJ, Rich NM. Aortic injuries in Vietnam. Surgery. 1971;70(3):385–391. PubMed

Dean NR, Ledgard JP, Katsaros J. Massive hemorrhage in facial fracture patients: definition, incidence, and management. Plast Reconstr Surg. 2009;123(2):680–690. doi: 10.1097/PRS.0b013e31819565da. PubMed DOI

Frakes MA, Evans T. Major pelvic fractures. Crit Care Nurse. 2004;24(2):18–30. PubMed

Grotz MR, Gummerson NW, Gansslen A, Petrowsky H, Keel M, Allami MK, et al. Staged management and outcome of combined pelvic and liver trauma. An international experience of the deadly duo. Injury. 2006;37(7):642–651. doi: 10.1016/j.injury.2005.11.009. PubMed DOI

Cryer HM, Miller FB, Evers BM, Rouben LR, Seligson DL. Pelvic fracture classification: correlation with hemorrhage. J Trauma. 1988;28(7):973–980. doi: 10.1097/00005373-198807000-00011. PubMed DOI

Burgess AR, Eastridge BJ, Young JW, Ellison TS, Ellison PS, Jr, Poka A, et al. Pelvic ring disruptions: effective classification system and treatment protocols. J Trauma. 1990;30(7):848–856. doi: 10.1097/00005373-199007000-00015. PubMed DOI

Eastridge BJ, Starr A, Minei JP, O’Keefe GE, Scalea TM. The importance of fracture pattern in guiding therapeutic decision-making in patients with hemorrhagic shock and pelvic ring disruptions. J Trauma. 2002;53(3):446–450. doi: 10.1097/00005373-200209000-00009. PubMed DOI

Manson TT, Nascone JW, O’Toole RV. Traction vertical shear pelvic ring fracture: a marker for severe arterial injury? A case report. J Orthop Trauma. 2010;24(10):e90–e94. doi: 10.1097/BOT.0b013e3181dc2443. PubMed DOI

Karmy-Jones R, Jurkovich GJ, Shatz DV, Brundage S, Wall MJ, Jr, Engelhardt S, et al. Management of traumatic lung injury: a Western Trauma Association multicenter review. J Trauma. 2001;51(6):1049–1053. doi: 10.1097/00005373-200112000-00004. PubMed DOI

de Lesquen H, Avaro J-P, Gust L, Ford RM, Beranger F, Natale C, et al. Surgical management for the first 48 h following blunt chest trauma: state of the art (excluding vascular injuries) Interact Cardiovasc Thorac Surg. 2015;20(3):399–408. doi: 10.1093/icvts/ivu397. PubMed DOI

Gillman LM, Ball CG, Panebianco N, Al-Kadi A, Kirkpatrick AW. Clinician performed resuscitative ultrasonography for the initial evaluation and resuscitation of trauma. Scand J Trauma Resusc Emerg Med. 2009;17:34. doi: 10.1186/1757-7241-17-34. PubMed DOI PMC

Stahel PF, Heyde CE, Wyrwich W, Ertel W. Current concepts of polytrauma management: from ATLS to “damage control”. Orthopade. 2005;34(9):823–836. doi: 10.1007/s00132-005-0842-5. PubMed DOI

Gebhard F, Huber-Lang M. Polytrauma--pathophysiology and management principles. Langenbecks Arch Surg. 2008;393(6):825–831. doi: 10.1007/s00423-008-0334-2. PubMed DOI

Huber-Wagner S, Lefering R, Qvick LM, Korner M, Kay MV, Pfeifer KJ, et al. Effect of whole-body CT during trauma resuscitation on survival: a retrospective, multicentre study. Lancet. 2009;373(9673):1455–1461. doi: 10.1016/S0140-6736(09)60232-4. PubMed DOI

Huber-Wagner S, Mand C, Ruchholtz S, Kuhne CA, Holzapfel K, Kanz KG, et al. Effect of the localisation of the CT scanner during trauma resuscitation on survival-A retrospective, multicentre study. Injury. 2014;45(Suppl 3):S76–S82. doi: 10.1016/j.injury.2014.08.022. PubMed DOI

Jorgensen H, Jensen CH, Dirks J. Does prehospital ultrasound improve treatment of the trauma patient? A systematic review. Eur J Emerg Med. 2010;17(5):249–253. doi: 10.1097/MEJ.0b013e328336adce. PubMed DOI

Rozycki GS, Newman PG. Surgeon-performed ultrasound for the assessment of abdominal injuries. Adv Surg. 1999;33:243–259. PubMed

Kretschmer KH, Hauser H. Radiologic diagnosis of abdominal trauma. Radiologe. 1998;38(8):693–701. doi: 10.1007/s001170050410. PubMed DOI

Brenchley J, Walker A, Sloan JP, Hassan TB, Venables H. Evaluation of focussed assessment with sonography in trauma (FAST) by UK emergency physicians. Emerg Med J. 2006;23(6):446–448. doi: 10.1136/emj.2005.026864. PubMed DOI PMC

Shackford SR, Rogers FB, Osler TM, Trabulsy ME, Clauss DW, Vane DW. Focused abdominal sonogram for trauma: the learning curve of nonradiologist clinicians in detecting hemoperitoneum. J Trauma. 1999;46(4):553–562. doi: 10.1097/00005373-199904000-00003. PubMed DOI

Richards JR, Schleper NH, Woo BD, Bohnen PA, McGahan JP. Sonographic assessment of blunt abdominal trauma: a 4-year prospective study. J Clin Ultrasound. 2002;30(2):59–67. doi: 10.1002/jcu.10033. PubMed DOI

Richards JR, Knopf NA, Wang L, McGahan JP. Blunt abdominal trauma in children: evaluation with emergency US. Radiology. 2002;222(3):749–754. doi: 10.1148/radiol.2223010838. PubMed DOI

Rose JS, Levitt MA, Porter J, Hutson A, Greenholtz J, Nobay F, et al. Does the presence of ultrasound really affect computed tomographic scan use? A prospective randomized trial of ultrasound in trauma. J Trauma. 2001;51(3):545–550. doi: 10.1097/00005373-200109000-00022. PubMed DOI

Stengel D, Bauwens K, Porzsolt F, Rademacher G, Mutze S, Ekkernkamp A. Emergency ultrasound for blunt abdominal trauma--meta-analysis update 2003. Zentralbl Chir. 2003;128(12):1027–1037. doi: 10.1055/s-2003-44850. PubMed DOI

Stengel D, Bauwens K, Rademacher G, Mutze S, Ekkernkamp A. Association between compliance with methodological standards of diagnostic research and reported test accuracy: meta-analysis of focused assessment of US for trauma. Radiology. 2005;236(1):102–111. doi: 10.1148/radiol.2361040791. PubMed DOI

Stengel D, Bauwens K, Sehouli J, Porzsolt F, Rademacher G, Mutze S, et al. Systematic review and meta-analysis of emergency ultrasonography for blunt abdominal trauma. Br J Surg. 2001;88(7):901–912. doi: 10.1046/j.0007-1323.2001.01777.x. PubMed DOI

Liu M, Lee CH, P’Eng FK. Prospective comparison of diagnostic peritoneal lavage, computed tomographic scanning, and ultrasonography for the diagnosis of blunt abdominal trauma. J Trauma. 1993;35(2):267–270. doi: 10.1097/00005373-199308000-00016. PubMed DOI

Quinn AC, Sinert R. What is the utility of the Focused Assessment with Sonography in Trauma (FAST) exam in penetrating torso trauma? Injury. 2011;42(5):482–487. doi: 10.1016/j.injury.2010.07.249. PubMed DOI

Fox JC, Boysen M, Gharahbaghian L, Cusick S, Ahmed SS, Anderson CL, et al. Test characteristics of focused assessment of sonography for trauma for clinically significant abdominal free fluid in pediatric blunt abdominal trauma. Acad Emerg Med. 2011;18(5):477–482. doi: 10.1111/j.1553-2712.2011.01071.x. PubMed DOI

Rohrl B, Sadick M, Diehl S, Obertacke U, Duber C. Whole-body MSCT of patients after polytrauma: abdominal injuries. Röfo. 2005;177(12):1641–1648. PubMed

Boehm T, Alkadhi H, Schertler T, Baumert B, Roos J, Marincek B, et al. Application of multislice spiral CT (MSCT) in multiple injured patients and its effect on diagnostic and therapeutic algorithms. Röfo. 2004;176(12):1734–1742. PubMed

Becker CD, Poletti PA. The trauma concept: the role of MDCT in the diagnosis and management of visceral injuries. Eur Radiol. 2005;15(Suppl 4):D105–D109. doi: 10.1007/s10406-005-0122-9. PubMed DOI

Weninger P, Mauritz W, Fridrich P, Spitaler R, Figl M, Kern B, et al. Emergency room management of patients with blunt major trauma: evaluation of the multislice computed tomography protocol exemplified by an urban trauma center. J Trauma. 2007;62(3):584–591. doi: 10.1097/01.ta.0000221797.46249.ee. PubMed DOI

Heyer CM, Rduch G, Kagel T, Lemburg SP, Theisinger A, Bauer TT, et al. Prospective randomized trial of a modified standard multislice CT protocol for the evaluation of multiple trauma patients. Röfo. 2005;177(2):242–249. PubMed

Navarrete-Navarro P, Vazquez G, Bosch JM, Fernandez E, Rivera R, Carazo E. Computed tomography vs clinical and multidisciplinary procedures for early evaluation of severe abdomen and chest trauma--a cost analysis approach. Intensive Care Med. 1996;22(3):208–212. doi: 10.1007/BF01712238. PubMed DOI

Atri M, Hanson JM, Grinblat L, Brofman N, Chughtai T, Tomlinson G. Surgically important bowel and/or mesenteric injury in blunt trauma: accuracy of multidetector CT for evaluation. Radiology. 2008;249(2):524–533. doi: 10.1148/radiol.2492072055. PubMed DOI

Marmery H, Shanmuganathan K. Multidetector-row computed tomography imaging of splenic trauma. Semin Ultrasound CT MR. 2006;27(5):404–419. doi: 10.1053/j.sult.2006.06.007. PubMed DOI

Anderson SW, Soto JA, Lucey BC, Burke PA, Hirsch EF, Rhea JT. Blunt trauma: feasibility and clinical utility of pelvic CT angiography performed with 64-detector row CT. Radiology. 2008;246(2):410–419. doi: 10.1148/radiol.2462070082. PubMed DOI

Anderson SW, Varghese JC, Lucey BC, Burke PA, Hirsch EF, Soto JA. Blunt splenic trauma: delayed-phase CT for differentiation of active hemorrhage from contained vascular injury in patients. Radiology. 2007;243(1):88–95. doi: 10.1148/radiol.2431060376. PubMed DOI

Fang JF, Chen RJ, Wong YC, Lin BC, Hsu YB, Kao JL, et al. Classification and treatment of pooling of contrast material on computed tomographic scan of blunt hepatic trauma. J Trauma. 2000;49(6):1083–1088. doi: 10.1097/00005373-200012000-00018. PubMed DOI

Tan KK, Liu JZ, Go TS, Vijayan A, Chiu MT. Computed tomography has an important role in hollow viscus and mesenteric injuries after blunt abdominal trauma. Injury. 2010;41(5):475–478. doi: 10.1016/j.injury.2009.09.028. PubMed DOI

Wu CH, Wang LJ, Wong YC, Fang JF, Lin BC, Chen HW, et al. Contrast-enhanced multiphasic computed tomography for identifying life-threatening mesenteric hemorrhage and transmural bowel injuries. J Trauma. 2011;71(3):543–548. doi: 10.1097/TA.0b013e3181fef15e. PubMed DOI

Linsenmaier U, Krotz M, Hauser H, Rock C, Rieger J, Bohndorf K, et al. Whole-body computed tomography in polytrauma: techniques and management. Eur Radiol. 2002;12(7):1728–1740. doi: 10.1007/s00330-001-1225-x. PubMed DOI

Albrecht T, von Schlippenbach J, Stahel PF, Ertel W, Wolf KJ. The role of whole body spiral CT in the primary work-up of polytrauma patients--comparison with conventional radiography and abdominal sonography. Röfo. 2004;176(8):1142–1150. PubMed

Ollerton JE, Sugrue M, Balogh Z, D’Amours SK, Giles A, Wyllie P. Prospective study to evaluate the influence of FAST on trauma patient management. J Trauma. 2006;60(4):785–791. doi: 10.1097/01.ta.0000214583.21492.e8. PubMed DOI

Farahmand N, Sirlin CB, Brown MA, Shragg GP, Fortlage D, Hoyt DB, et al. Hypotensive patients with blunt abdominal trauma: performance of screening US. Radiology. 2005;235(2):436–443. doi: 10.1148/radiol.2352040583. PubMed DOI

Kirkpatrick AW, Ball CG, D’Amours SK, Zygun D. Acute resuscitation of the unstable adult trauma patient: bedside diagnosis and therapy. Can J Surg. 2008;51(1):57–69. PubMed PMC

Wherrett LJ, Boulanger BR, McLellan BA, Brenneman FD, Rizoli SB, Culhane J, et al. Hypotension after blunt abdominal trauma: the role of emergent abdominal sonography in surgical triage. J Trauma. 1996;41(5):815–820. doi: 10.1097/00005373-199611000-00008. PubMed DOI

Rozycki GS, Ballard RB, Feliciano DV, Schmidt JA, Pennington SD. Surgeon-performed ultrasound for the assessment of truncal injuries: lessons learned from 1540 patients. Ann Surg. 1998;228(4):557–567. doi: 10.1097/00000658-199810000-00012. PubMed DOI PMC

Caleo O, Bocchini G, Paoletta S, Ierardi AM, Scionti A, Tonerini M, et al. Spontaneous non-aortic retroperitoneal hemorrhage: etiology, imaging characterization and impact of MDCT on management. A multicentric study. Radiol Med. 2015;120(1):133–148. doi: 10.1007/s11547-014-0482-0. PubMed DOI

Hauschild O, Aghayev E, von Heyden J, Strohm PC, Culemann U, Pohlemann T, et al. Angioembolization for pelvic hemorrhage control: results from the German pelvic injury register. J Trauma Acute Care Surg. 2012;73(3):679–684. doi: 10.1097/TA.0b013e318253b5ba. PubMed DOI

Chao NS, Liu CS, Chung KL, Tang PM, Tai DK, Lee KY, et al. Retroperitoneal pelvic packing for haemodynamically unstable pelvic fractures in children and adolescents: a level-one trauma-centre experience. J Pediatr Surg. 2012;47(12):2244–2250. doi: 10.1016/j.jpedsurg.2012.09.015. PubMed DOI

Heetveld MJ, Harris I, Schlaphoff G, Balogh Z, D’Amours SK, Sugrue M. Hemodynamically unstable pelvic fractures: recent care and new guidelines. World J Surg. 2004;28(9):904–909. doi: 10.1007/s00268-004-7357-9. PubMed DOI

Paradis NA, Balter S, Davison CM, Simon G, Rose M. Hematocrit as a predictor of significant injury after penetrating trauma. Am J Emerg Med. 1997;15(3):224–228. doi: 10.1016/S0735-6757(97)90001-2. PubMed DOI

Zehtabchi S, Sinert R, Goldman M, Kapitanyan R, Ballas J. Diagnostic performance of serial haematocrit measurements in identifying major injury in adult trauma patients. Injury. 2006;37(1):46–52. doi: 10.1016/j.injury.2005.09.015. PubMed DOI

Snyder HS. Significance of the initial spun hematocrit in trauma patients. Am J Emerg Med. 1998;16(2):150–153. doi: 10.1016/S0735-6757(98)90033-X. PubMed DOI

Greenfield RH, Bessen HA, Henneman PL. Effect of crystalloid infusion on hematocrit and intravascular volume in healthy, nonbleeding subjects. Ann Emerg Med. 1989;18(1):51–55. doi: 10.1016/S0196-0644(89)80312-9. PubMed DOI

Kass LE, Tien IY, Ushkow BS, Snyder HS. Prospective crossover study of the effect of phlebotomy and intravenous crystalloid on hematocrit. Acad Emerg Med. 1997;4(3):198–201. doi: 10.1111/j.1553-2712.1997.tb03740.x. PubMed DOI

Stamler KD. Effect of crystalloid infusion on hematocrit in nonbleeding patients, with applications to clinical traumatology. Ann Emerg Med. 1989;18(7):747–749. doi: 10.1016/S0196-0644(89)80008-3. PubMed DOI

Ryan ML, Thorson CM, Otero CA, Vu T, Schulman CI, Livingstone AS, et al. Initial hematocrit in trauma: a paradigm shift? J Trauma Acute Care Surg. 2012;72(1):54–59. PubMed

Thorson CM, Van Haren RM, Ryan ML, Pereira R, Olloqui J, Guarch GA, et al. Admission hematocrit and transfusion requirements after trauma. J Am Coll Surg. 2013;216(1):65–73. doi: 10.1016/j.jamcollsurg.2012.09.011. PubMed DOI

Vandromme MJ, Griffin RL, Kerby JD, McGwin G, Jr, Rue LW, 3rd, Weinberg JA. Identifying risk for massive transfusion in the relatively normotensive patient: utility of the prehospital shock index. J Trauma. 2011;70(2):384–388. doi: 10.1097/TA.0b013e3182095a0a. PubMed DOI

Thorson CM, Ryan ML, Van Haren RM, Pereira R, Olloqui J, Otero CA, et al. Change in hematocrit during trauma assessment predicts bleeding even with ongoing fluid resuscitation. Am Surg. 2013;79(4):398–406. PubMed

Schlimp CJ, Voelckel W, Inaba K, Maegele M, Ponschab M, Schochl H. Estimation of plasma fibrinogen levels based on hemoglobin, base excess and Injury Severity Score upon emergency room admission. Crit Care. 2013;17(4):R137. doi: 10.1186/cc12816. PubMed DOI PMC

Broder G, Weil MH. Excess lactate: an index of reversibility of shock in human patients. Science. 1964;143(3613):1457–1459. doi: 10.1126/science.143.3613.1457. PubMed DOI

Wilson M, Davis DP, Coimbra R. Diagnosis and monitoring of hemorrhagic shock during the initial resuscitation of multiple trauma patients: a review. J Emerg Med. 2003;24(4):413–422. doi: 10.1016/S0736-4679(03)00042-8. PubMed DOI

Baron BJ, Scalea TM. Acute blood loss. Emerg Med Clin North Am. 1996;14(1):35–55. doi: 10.1016/S0733-8627(05)70237-6. PubMed DOI

Porter JM, Ivatury RR. In search of the optimal end points of resuscitation in trauma patients: a review. J Trauma. 1998;44(5):908–914. doi: 10.1097/00005373-199805000-00028. PubMed DOI

Bilkovski RN, Rivers EP, Horst HM. Targeted resuscitation strategies after injury. Curr Opin Crit Care. 2004;10(6):529–538. doi: 10.1097/01.ccx.0000144771.96342.2c. PubMed DOI

Vincent JL, Dufaye P, Berre J, Leeman M, Degaute JP, Kahn RJ. Serial lactate determinations during circulatory shock. Crit Care Med. 1983;11(6):449–451. doi: 10.1097/00003246-198306000-00012. PubMed DOI

Abramson D, Scalea TM, Hitchcock R, Trooskin SZ, Henry SM, Greenspan J. Lactate clearance and survival following injury. J Trauma. 1993;35(4):584–588. doi: 10.1097/00005373-199310000-00014. PubMed DOI

Manikis P, Jankowski S, Zhang H, Kahn RJ, Vincent JL. Correlation of serial blood lactate levels to organ failure and mortality after trauma. Am J Emerg Med. 1995;13(6):619–622. doi: 10.1016/0735-6757(95)90043-8. PubMed DOI

Caputo N, Fraser R, Paliga A, Kanter M, Hosford K, Madlinger R. Triage vital signs do not correlate with serum lactate or base deficit, and are less predictive of operative intervention in penetrating trauma patients: a prospective cohort study. Emerg Med J. 2013;30(7):546–550. doi: 10.1136/emermed-2012-201343. PubMed DOI

Herbert HK, Dechert TA, Wolfe L, Aboutanos MB, Malhotra AK, Ivatury RR, et al. Lactate in trauma: a poor predictor of mortality in the setting of alcohol ingestion. Am Surg. 2011;77(12):1576–1579. PubMed

Gustafson ML, Hollosi S, Chumbe JT, Samanta D, Modak A, Bethea A. The effect of ethanol on lactate and base deficit as predictors of morbidity and mortality in trauma. Am J Emerg Med. 2015;33(5):607–613. doi: 10.1016/j.ajem.2015.01.030. PubMed DOI PMC

Arnold TD, Miller M, van Wessem KP, Evans JA, Balogh ZJ. Base deficit from the first peripheral venous sample: a surrogate for arterial base deficit in the trauma bay. J Trauma. 2011;71(4):793–797. doi: 10.1097/TA.0b013e31822ad694. PubMed DOI

Davis JW, Parks SN, Kaups KL, Gladen HE, O’Donnell-Nicol S. Admission base deficit predicts transfusion requirements and risk of complications. J Trauma. 1996;41(5):769–774. doi: 10.1097/00005373-199611000-00001. PubMed DOI

Davis JW, Kaups KL, Parks SN. Base deficit is superior to pH in evaluating clearance of acidosis after traumatic shock. J Trauma. 1998;44(1):114–118. doi: 10.1097/00005373-199801000-00014. PubMed DOI

Mutschler M, Nienaber U, Brockamp T, Wafaisade A, Fabian T, Paffrath T, et al. Renaissance of base deficit for the initial assessment of trauma patients: a base deficit-based classification for hypovolemic shock developed on data from 16,305 patients derived from the TraumaRegister DGU(R) Crit Care. 2013;17(2):R42. doi: 10.1186/cc12555. PubMed DOI PMC

Davis JW, Kaups KL. Base deficit in the elderly: a marker of severe injury and death. J Trauma. 1998;45(5):873–877. doi: 10.1097/00005373-199811000-00005. PubMed DOI

Randolph LC, Takacs M, Davis KA. Resuscitation in the pediatric trauma population: admission base deficit remains an important prognostic indicator. J Trauma. 2002;53(5):838–842. doi: 10.1097/00005373-200211000-00006. PubMed DOI

Mikulaschek A, Henry SM, Donovan R, Scalea TM. Serum lactate is not predicted by anion gap or base excess after trauma resuscitation. J Trauma. 1996;40(2):218–222. doi: 10.1097/00005373-199602000-00008. PubMed DOI

Mann KG, Butenas S, Brummel K. The dynamics of thrombin formation. Arterioscler Thromb Vasc Biol. 2003;23(1):17–25. doi: 10.1161/01.ATV.0000046238.23903.FC. PubMed DOI

Levrat A, Gros A, Rugeri L, Inaba K, Floccard B, Negrier C, et al. Evaluation of rotation thrombelastography for the diagnosis of hyperfibrinolysis in trauma patients. Br J Anaesth. 2008;100(6):792–797. doi: 10.1093/bja/aen083. PubMed DOI

Johansson PI, Stensballe J. Effect of haemostatic control resuscitation on mortality in massively bleeding patients: a before and after study. Vox Sang. 2009;96(2):111–118. doi: 10.1111/j.1423-0410.2008.01130.x. PubMed DOI PMC

Davenport R, Manson J, De’Ath H, Platton S, Coates A, Allard S, et al. Functional definition and characterization of acute traumatic coagulopathy. Crit Care Med. 2011;39(12):2652–2658. doi: 10.1097/CCM.0b013e3182281af5. PubMed DOI PMC

Tauber H, Innerhofer P, Breitkopf R, Westermann I, Beer R, El Attal R, et al. Prevalence and impact of abnormal ROTEM(R) assays in severe blunt trauma: results of the ‘Diagnosis and Treatment of Trauma-Induced Coagulopathy (DIA-TRE-TIC) study’. Br J Anaesth. 2011;107(3):378–387. doi: 10.1093/bja/aer158. PubMed DOI

Theusinger OM, Wanner GA, Emmert MY, Billeter A, Eismon J, Seifert B, et al. Hyperfibrinolysis diagnosed by rotational thromboelastometry (ROTEM) is associated with higher mortality in patients with severe trauma. Anesth Analg. 2011;113(5):1003–1012. doi: 10.1213/ANE.0b013e31822e183f. PubMed DOI

Haas T, Spielmann N, Mauch J, Madjdpour C, Speer O, Schmugge M, et al. Comparison of thromboelastometry (ROTEM(R)) with standard plasmatic coagulation testing in paediatric surgery. Br J Anaesth. 2012;108(1):36–41. doi: 10.1093/bja/aer342. PubMed DOI

Haas T, Spielmann N, Mauch J, Speer O, Schmugge M, Weiss M. Reproducibility of thrombelastometry (ROTEM(R)): point-of-care versus hospital laboratory performance. Scand J Clin Lab Invest. 2012;72(4):313–317. doi: 10.3109/00365513.2012.665474. PubMed DOI

McCrath DJ, Cerboni E, Frumento RJ, Hirsh AL, Bennett-Guerrero E. Thromboelastography maximum amplitude predicts postoperative thrombotic complications including myocardial infarction. Anesth Analg. 2005;100(6):1576–1583. doi: 10.1213/01.ANE.0000155290.86795.12. PubMed DOI

Kashuk JL, Moore EE, Sabel A, Barnett C, Haenel J, Le T, et al. Rapid thrombelastography (r-TEG) identifies hypercoagulability and predicts thromboembolic events in surgical patients. Surgery. 2009;146(4):764–772. doi: 10.1016/j.surg.2009.06.054. PubMed DOI

Johansson PI, Stensballe J, Vindelov N, Perner A, Espersen K. Hypocoagulability, as evaluated by thrombelastography, at admission to the ICU is associated with increased 30-day mortality. Blood Coagul Fibrinolysis. 2010;21(2):168–174. doi: 10.1097/MBC.0b013e3283367882. PubMed DOI

Leemann H, Lustenberger T, Talving P, Kobayashi L, Bukur M, Brenni M, et al. The role of rotation thromboelastometry in early prediction of massive transfusion. J Trauma. 2010;69(6):1403–1408. doi: 10.1097/TA.0b013e3181faaa25. PubMed DOI

Cotton BA, Faz G, Hatch QM, Radwan ZA, Podbielski J, Wade C, et al. Rapid thrombelastography delivers real-time results that predict transfusion within 1 hour of admission. J Trauma. 2011;71(2):407–414. doi: 10.1097/TA.0b013e31821e1bf0. PubMed DOI

Schöchl H, Cotton B, Inaba K, Nienaber U, Fischer H, Voelckel W, et al. FIBTEM provides early prediction of massive transfusion in trauma. Crit Care. 2011;15(6):R265. doi: 10.1186/cc10539. PubMed DOI PMC

Windeløv NA, Welling KL, Ostrowski SR, Johansson PI. The prognostic value of thrombelastography in identifying neurosurgical patients with worse prognosis. Blood Coagul Fibrinolysis. 2011;22(5):416–419. doi: 10.1097/MBC.0b013e3283464f53. PubMed DOI

Cotton BA, Minei KM, Radwan ZA, Matijevic N, Pivalizza E, Podbielski J, et al. Admission rapid thrombelastography predicts development of pulmonary embolism in trauma patients. J Trauma Acute Care Surg. 2012;72(6):1470–1475. doi: 10.1097/TA.0b013e31824d56ad. PubMed DOI

Kunio NR, Differding JA, Watson KM, Stucke RS, Schreiber MA. Thrombelastography-identified coagulopathy is associated with increased morbidity and mortality after traumatic brain injury. Am J Surg. 2012;203(5):584–588. doi: 10.1016/j.amjsurg.2011.12.011. PubMed DOI

Pezold M, Moore EE, Wohlauer M, Sauaia A, Gonzalez E, Banerjee A, et al. Viscoelastic clot strength predicts coagulation-related mortality within 15 minutes. Surgery. 2012;151(1):48–54. doi: 10.1016/j.surg.2011.06.023. PubMed DOI PMC

Rattanabannakit C, Nilanont Y, Komoltri C, Prayoonwiwat N, Poungvarin N. Accuracy and clinical utility of a portable coagulometer in an emergency setting. J Med Assoc Thai. 2011;94(Suppl 1):S89–S93. PubMed

Celenza A, Skinner K. Comparison of emergency department point-of-care international normalised ratio (INR) testing with laboratory-based testing. Emerg Med J. 2011;28(2):136–140. doi: 10.1136/emj.2009.086520. PubMed DOI

David JS, Levrat A, Inaba K, Macabeo C, Rugeri L, Fontaine O, et al. Utility of a point-of-care device for rapid determination of prothrombin time in trauma patients: a preliminary study. J Trauma Acute Care Surg. 2012;72(3):703–707. doi: 10.1097/TA.0b013e31822c884d. PubMed DOI

Gauss T, Hamada S, Jurcisin I, Dahmani S, Boudaoud L, Mantz J, et al. Limits of agreement between measures obtained from standard laboratory and the point-of-care device Hemochron Signature Elite(R) during acute haemorrhage. Br J Anaesth. 2014;112(3):514–520. doi: 10.1093/bja/aet384. PubMed DOI

Chitlur M, Lusher J. Standardization of thromboelastography: values and challenges. Semin Thromb Hemost. 2010;36(7):707–711. doi: 10.1055/s-0030-1265287. PubMed DOI

Chitlur M, Sorensen B, Rivard GE, Young G, Ingerslev J, Othman M, et al. Standardization of thromboelastography: a report from the TEG-ROTEM working group. Haemophilia. 2011;17(3):532–537. doi: 10.1111/j.1365-2516.2010.02451.x. PubMed DOI

Görlinger K, Dirkmann D, Hanke AA, Kamler M, Kottenberg E, Thielmann M, et al. First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: a retrospective, single-center cohort study. Anesthesiology. 2011;115(6):1179–1191. PubMed

Jeger V, Zimmermann H, Exadaktylos AK. Can RapidTEG accelerate the search for coagulopathies in the patient with multiple injuries? J Trauma. 2009;66(4):1253–1257. doi: 10.1097/TA.0b013e31819d3caf. PubMed DOI

Hunt H, Stanworth S, Curry N, Woolley T, Cooper C, Ukoumunne O, et al. Thromboelastography (TEG) and rotational thromboelastometry (ROTEM) for trauma induced coagulopathy in adult trauma patients with bleeding. Cochrane Database Syst Rev. 2015;2:CD010438. PubMed PMC

Da Luz LT, Nascimento B, Shankarakutty AK, Rizoli S, Adhikari NK. Effect of thromboelastography (TEG(R)) and rotational thromboelastometry (ROTEM(R)) on diagnosis of coagulopathy, transfusion guidance and mortality in trauma: descriptive systematic review. Crit Care. 2014;18(5):518. doi: 10.1186/s13054-014-0518-9. PubMed DOI PMC

Larsen OH, Fenger-Eriksen C, Christiansen K, Ingerslev J, Sorensen B. Diagnostic performance and therapeutic consequence of thromboelastometry activated by kaolin versus a panel of specific reagents. Anesthesiology. 2011;115(2):294–302. doi: 10.1097/ALN.0b013e318220755c. PubMed DOI

Harr JN, Moore EE, Ghasabyan A, Chin TL, Sauaia A, Banerjee A, et al. Functional fibrinogen assay indicates that fibrinogen is critical in correcting abnormal clot strength following trauma. Shock. 2013;39(1):45–49. PubMed PMC

Holcomb JB, Minei KM, Scerbo ML, Radwan ZA, Wade CE, Kozar RA, et al. Admission rapid thrombelastography can replace conventional coagulation tests in the emergency department: experience with 1974 consecutive trauma patients. Ann Surg. 2012;256(3):476–486. doi: 10.1097/SLA.0b013e3182658180. PubMed DOI

Vogel AM, Radwan ZA, Cox CS, Jr, Cotton BA. Admission rapid thrombelastography delivers real-time “actionable” data in pediatric trauma. J Pediatr Surg. 2013;48(6):1371–1376. doi: 10.1016/j.jpedsurg.2013.03.036. PubMed DOI

Agren A, Wikman AT, Holmstrom M, Ostlund A, Edgren G. Thromboelastography (TEG(R)) compared to conventional coagulation tests in surgical patients--a laboratory evaluation. Scand J Clin Lab Invest. 2013;73(3):214–220. doi: 10.3109/00365513.2013.765960. PubMed DOI

Agren A, Wikman AT, Ostlund A, Edgren G. TEG(R) functional fibrinogen analysis may overestimate fibrinogen levels. Anesth Analg. 2014;118(5):933–935. doi: 10.1213/ANE.0000000000000172. PubMed DOI

Hagemo JS, Naess PA, Johansson P, Windelov NA, Cohen MJ, Roislien J, et al. Evaluation of TEG((R)) and RoTEM((R)) inter-changeability in trauma patients. Injury. 2013;44(5):600–605. doi: 10.1016/j.injury.2012.11.016. PubMed DOI

Hanke AA, Roberg K, Monaca E, Sellmann T, Weber CF, Rahe-Meyer N, et al. Impact of platelet count on results obtained from multiple electrode platelet aggregometry (Multiplate) Eur J Med Res. 2010;15(5):214–219. PubMed PMC

Solomon C, Traintinger S, Ziegler B, Hanke A, Rahe-Meyer N, Voelckel W, et al. Platelet function following trauma. A multiple electrode aggregometry study. Thromb Haemost. 2011;106(2):322–330. doi: 10.1160/TH11-03-0175. PubMed DOI

Lang T, von Depka M. Possibilities and limitations of thrombelastometry/-graphy. Hamostaseologie. 2006;26(3 Suppl 1):S20–S29. PubMed

Waydhas C, German Society of Trauma Surgery (DGU) Preclinical management of multiples injuries: S3 guideline. Unfallchirurg. 2012;115(1):8–13. doi: 10.1007/s00113-011-2102-y. PubMed DOI

Bickell WH, Wall MJ, Jr, Pepe PE, Martin RR, Ginger VF, Allen MK, et al. Immediate versus delayed fluid resuscitation for hypotensive patients with penetrating torso injuries. N Engl J Med. 1994;331(17):1105–1109. doi: 10.1056/NEJM199410273311701. PubMed DOI

Sampalis JS, Tamim H, Denis R, Boukas S, Ruest SA, Nikolis A, et al. Ineffectiveness of on-site intravenous lines: is prehospital time the culprit? J Trauma. 1997;43(4):608–615. doi: 10.1097/00005373-199710000-00008. PubMed DOI

Dutton RP, Mackenzie CF, Scalea TM. Hypotensive resuscitation during active hemorrhage: impact on in-hospital mortality. J Trauma. 2002;52(6):1141–1146. doi: 10.1097/00005373-200206000-00020. PubMed DOI

Turner J, Nicholl J, Webber L, Cox H, Dixon S, Yates D. A randomised controlled trial of prehospital intravenous fluid replacement therapy in serious trauma. Health Technol Assess. 2000;4(31):1–57. PubMed

Madigan MC, Kemp CD, Johnson JC, Cotton BA. Secondary abdominal compartment syndrome after severe extremity injury: are early, aggressive fluid resuscitation strategies to blame? J Trauma. 2008;64(2):280–285. doi: 10.1097/TA.0b013e3181622bb6. PubMed DOI

Haut ER, Kalish BT, Cotton BA, Efron DT, Haider AH, Stevens KA, et al. Prehospital intravenous fluid administration is associated with higher mortality in trauma patients: a National Trauma Data Bank analysis. Ann Surg. 2011;253(2):371–377. doi: 10.1097/SLA.0b013e318207c24f. PubMed DOI

Champion HR. Prehospital intravenous fluid administration is associated with higher mortality in trauma patients. Ann Surg. 2014;259(2):e19. doi: 10.1097/SLA.0b013e3182456b51. PubMed DOI

Morrison CA, Carrick MM, Norman MA, Scott BG, Welsh FJ, Tsai P, et al. Hypotensive resuscitation strategy reduces transfusion requirements and severe postoperative coagulopathy in trauma patients with hemorrhagic shock: preliminary results of a randomized controlled trial. J Trauma. 2011;70(3):652–663. doi: 10.1097/TA.0b013e31820e77ea. PubMed DOI

Brown JB, Cohen MJ, Minei JP, Maier RV, West MA, Billiar TR, et al. Goal-directed resuscitation in the prehospital setting: a propensity-adjusted analysis. J Trauma Acute Care Surg. 2013;74(5):1207–1212. doi: 10.1097/TA.0b013e31828c44fd. PubMed DOI PMC

Schreiber MA, Meier EN, Tisherman SA, Kerby JD, Newgard CD, Brasel K, et al. A controlled resuscitation strategy is feasible and safe in hypotensive trauma patients: results of a prospective randomized pilot trial. J Trauma Acute Care Surg. 2015;78(4):687–695. doi: 10.1097/TA.0000000000000600. PubMed DOI PMC

Kwan I, Bunn F, Roberts I. Timing and volume of fluid administration for patients with bleeding. Cochrane Database Syst Rev. 2003;3:CD002245. PubMed

Wang CH, Hsieh WH, Chou HC, Huang YS, Shen JH, Yeo YH, et al. Liberal versus restricted fluid resuscitation strategies in trauma patients: a systematic review and meta-analysis of randomized controlled trials and observational studies*. Crit Care Med. 2014;42(4):954–961. doi: 10.1097/CCM.0000000000000050. PubMed DOI

Berry C, Ley EJ, Bukur M, Malinoski D, Margulies DR, Mirocha J, et al. Redefining hypotension in traumatic brain injury. Injury. 2012;43(11):1833–1837. doi: 10.1016/j.injury.2011.08.014. PubMed DOI

Brenner M, Stein DM, Hu PF, Aarabi B, Sheth K, Scalea TM. Traditional systolic blood pressure targets underestimate hypotension-induced secondary brain injury. J Trauma Acute Care Surg. 2012;72(5):1135–1139. doi: 10.1097/TA.0b013e31824af90b. PubMed DOI

Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013;41(2):580–637. doi: 10.1097/CCM.0b013e31827e83af. PubMed DOI

Imai Y, Satoh K, Taira N. Role of the peripheral vasculature in changes in venous return caused by isoproterenol, norepinephrine, and methoxamine in anesthetized dogs. Circ Res. 1978;43(4):553–561. doi: 10.1161/01.RES.43.4.553. PubMed DOI

Gelman S, Mushlin PS. Catecholamine-induced changes in the splanchnic circulation affecting systemic hemodynamics. Anesthesiology. 2004;100(2):434–439. doi: 10.1097/00000542-200402000-00036. PubMed DOI

Poloujadoff MP, Borron SW, Amathieu R, Favret F, Camara MS, Lapostolle F, et al. Improved survival after resuscitation with norepinephrine in a murine model of uncontrolled hemorrhagic shock. Anesthesiology. 2007;107(4):591–596. doi: 10.1097/01.anes.0000281926.54940.6a. PubMed DOI

Harrois A, Baudry N, Huet O, Kato H, Dupic L, Lohez M, et al. Norepinephrine decreases fluid requirements and blood loss while preserving intestinal villi microcirculation during fluid resuscitation of uncontrolled hemorrhagic shock in mice. Anesthesiology. 2015;122(5):1093–1102. doi: 10.1097/ALN.0000000000000639. PubMed DOI

Sperry JL, Minei JP, Frankel HL, West MA, Harbrecht BG, Moore EE, et al. Early use of vasopressors after injury: caution before constriction. J Trauma. 2008;64(1):9–14. doi: 10.1097/TA.0b013e31815dd029. PubMed DOI

Cohn SM, McCarthy J, Stewart RM, Jonas RB, Dent DL, Michalek JE. Impact of low-dose vasopressin on trauma outcome: prospective randomized study. World J Surg. 2011;35(2):430–439. doi: 10.1007/s00268-010-0875-8. PubMed DOI

Chowdhury AH, Cox EF, Francis ST, Lobo DN. A randomized, controlled, double-blind crossover study on the effects of 2-L infusions of 0.9 % saline and plasma-lyte(R) 148 on renal blood flow velocity and renal cortical tissue perfusion in healthy volunteers. Ann Surg. 2012;256(1):18–24. doi: 10.1097/SLA.0b013e318256be72. PubMed DOI

Yunos NM, Bellomo R, Hegarty C, Story D, Ho L, Bailey M. Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults. JAMA. 2012;308(15):1566–1572. doi: 10.1001/jama.2012.13356. PubMed DOI

Young JB, Utter GH, Schermer CR, Galante JM, Phan HH, Yang Y, et al. Saline versus Plasma-Lyte A in initial resuscitation of trauma patients: a randomized trial. Ann Surg. 2014;259(2):255–262. doi: 10.1097/SLA.0b013e318295feba. PubMed DOI

Smith CA, Duby JJ, Utter GH, Galante JM, Scherer LA, Schermer CR. Cost-minimization analysis of two fluid products for resuscitation of critically injured trauma patients. Am J Health Syst Pharm. 2014;71(6):470–475. doi: 10.2146/ajhp130295. PubMed DOI

Aoki K, Yoshino A, Yoh K, Sekine K, Yamazaki M, Aikawa N. A comparison of Ringer’s lactate and acetate solutions and resuscitative effects on splanchnic dysoxia in patients with extensive burns. Burns. 2010;36(7):1080–1085. doi: 10.1016/j.burns.2010.04.002. PubMed DOI

Orbegozo Cortes D, Rayo Bonor A, Vincent JL. Isotonic crystalloid solutions: a structured review of the literature. Br J Anaesth. 2014;112(6):968–981. doi: 10.1093/bja/aeu047. PubMed DOI

Perel P, Roberts I, Ker K. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev. 2013;2:CD000567. PubMed

Brakenridge SC, Phelan HA, Henley SS, Golden RM, Kashner TM, Eastman AE, et al. Early blood product and crystalloid volume resuscitation: risk association with multiple organ dysfunction after severe blunt traumatic injury. J Trauma. 2011;71(2):299–305. doi: 10.1097/TA.0b013e318224d328. PubMed DOI PMC

Spoerke N, Michalek J, Schreiber M, Brasel KJ, Vercruysse G, MacLeod J, et al. Crystalloid resuscitation improves survival in trauma patients receiving low ratios of fresh frozen plasma to packed red blood cells. J Trauma. 2011;71(2 Suppl 3):S380–S383. doi: 10.1097/TA.0b013e318227f1c5. PubMed DOI

Bunn F, Trivedi D, Ashraf S. Colloid solutions for fluid resuscitation. Cochrane Database Syst Rev. 2011;3:CD001319. PubMed

Rochwerg B, Alhazzani W, Sindi A, Heels-Ansdell D, Thabane L, Fox-Robichaud A, et al. Fluid resuscitation in sepsis: a systematic review and network meta-analysis. Ann Intern Med. 2014;161(5):347–355. doi: 10.7326/M14-0178. PubMed DOI

Serpa Neto A, Veelo DP, Peireira VG, de Assuncao MS, Manetta JA, Esposito DC, et al. Fluid resuscitation with hydroxyethyl starches in patients with sepsis is associated with an increased incidence of acute kidney injury and use of renal replacement therapy: a systematic review and meta-analysis of the literature. J Crit Care. 2014;29(1):185. doi: 10.1016/j.jcrc.2013.09.031. PubMed DOI

Gillies MA, Habicher M, Jhanji S, Sander M, Mythen M, Hamilton M, et al. Incidence of postoperative death and acute kidney injury associated with i.v. 6 % hydroxyethyl starch use: systematic review and meta-analysis. Br J Anaesth. 2014;112(1):25–34. doi: 10.1093/bja/aet303. PubMed DOI

Kind SL, Spahn-Nett GH, Emmert MY, Eismon J, Seifert B, Spahn DR, et al. Is dilutional coagulopathy induced by different colloids reversible by replacement of fibrinogen and factor XIII concentrates? Anesth Analg. 2013;117(5):1063–1071. doi: 10.1213/ANE.0b013e3182a52876. PubMed DOI

James MF, Michell WL, Joubert IA, Nicol AJ, Navsaria PH, Gillespie RS. Resuscitation with hydroxyethyl starch improves renal function and lactate clearance in penetrating trauma in a randomized controlled study: the FIRST trial (Fluids in Resuscitation of Severe Trauma) Br J Anaesth. 2011;107(5):693–702. doi: 10.1093/bja/aer229. PubMed DOI

Bulger EM, Jurkovich GJ, Nathens AB, Copass MK, Hanson S, Cooper C, et al. Hypertonic resuscitation of hypovolemic shock after blunt trauma: a randomized controlled trial. Arch Surg. 2008;143(2):139–148. doi: 10.1001/archsurg.2007.41. PubMed DOI

Battison C, Andrews PJ, Graham C, Petty T. Randomized, controlled trial on the effect of a 20 % mannitol solution and a 7.5 % saline/6 % dextran solution on increased intracranial pressure after brain injury. Crit Care Med. 2005;33(1):196–202. doi: 10.1097/01.CCM.0000150269.65485.A6. PubMed DOI

Cooper DJ, Myles PS, McDermott FT, Murray LJ, Laidlaw J, Cooper G, et al. Prehospital hypertonic saline resuscitation of patients with hypotension and severe traumatic brain injury: a randomized controlled trial. JAMA. 2004;291(11):1350–1357. doi: 10.1001/jama.291.11.1350. PubMed DOI

Bulger EM, May S, Brasel KJ, Schreiber M, Kerby JD, Tisherman SA, et al. Out-of-hospital hypertonic resuscitation following severe traumatic brain injury: a randomized controlled trial. JAMA. 2010;304(13):1455–1464. doi: 10.1001/jama.2010.1405. PubMed DOI PMC

Bulger EM, May S, Kerby JD, Emerson S, Stiell IG, Schreiber MA, et al. Out-of-hospital hypertonic resuscitation after traumatic hypovolemic shock: a randomized, placebo controlled trial. Ann Surg. 2011;253(3):431–441. doi: 10.1097/SLA.0b013e3181fcdb22. PubMed DOI PMC

Delano MJ, Rizoli SB, Rhind SG, Cuschieri J, Junger W, Baker AJ, et al. Prehospital resuscitation of traumatic hemorrhagic shock with hypertonic solutions worsens hypocoagulation and hyperfibrinolysis. Shock. 2015;44(1):25–31. doi: 10.1097/SHK.0000000000000368. PubMed DOI PMC

Wade CE, Grady JJ, Kramer GC. Efficacy of hypertonic saline dextran fluid resuscitation for patients with hypotension from penetrating trauma. J Trauma. 2003;54(5 Suppl):S144–S148. PubMed

Hebert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med. 1999;340(6):409–417. doi: 10.1056/NEJM199902113400601. PubMed DOI

Holst LB, Haase N, Wetterslev J, Wernerman J, Guttormsen AB, Karlsson S, et al. Lower versus higher hemoglobin threshold for transfusion in septic shock. N Engl J Med. 2014;371(15):1381–1391. doi: 10.1056/NEJMoa1406617. PubMed DOI

Hajjar LA, Vincent JL, Galas FR, Nakamura RE, Silva CM, Santos MH, et al. Transfusion requirements after cardiac surgery: the TRACS randomized controlled trial. JAMA. 2010;304(14):1559–1567. doi: 10.1001/jama.2010.1446. PubMed DOI

Villanueva C, Colomo A, Bosch A, Concepcion M, Hernandez-Gea V, Aracil C, et al. Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med. 2013;368(1):11–21. doi: 10.1056/NEJMoa1211801. PubMed DOI

Murphy GJ, Pike K, Rogers CA, Wordsworth S, Stokes EA, Angelini GD, et al. Liberal or restrictive transfusion after cardiac surgery. N Engl J Med. 2015;372(11):997–1008. doi: 10.1056/NEJMoa1403612. PubMed DOI

McIntyre L, Hebert PC, Wells G, Fergusson D, Marshall J, Yetisir E, et al. Is a restrictive transfusion strategy safe for resuscitated and critically ill trauma patients? J Trauma. 2004;57(3):563–568. doi: 10.1097/01.TA.0000136158.93864.54. PubMed DOI

Malone DL, Dunne J, Tracy JK, Putnam AT, Scalea TM, Napolitano LM. Blood transfusion, independent of shock severity, is associated with worse outcome in trauma. J Trauma. 2003;54(5):898–905. doi: 10.1097/01.TA.0000060261.10597.5C. PubMed DOI

Charles A, Shaikh AA, Walters M, Huehl S, Pomerantz R. Blood transfusion is an independent predictor of mortality after blunt trauma. Am Surg. 2007;73(1):1–5. PubMed

Robinson WP, 3rd, Ahn J, Stiffler A, Rutherford EJ, Hurd H, Zarzaur BL, et al. Blood transfusion is an independent predictor of increased mortality in nonoperatively managed blunt hepatic and splenic injuries. J Trauma. 2005;58(3):437–444. doi: 10.1097/01.TA.0000153935.18997.14. PubMed DOI

Weinberg JA, McGwin G, Jr, Marques MB, Cherry SA, 3rd, Reiff DA, Kerby JD, et al. Transfusions in the less severely injured: does age of transfused blood affect outcomes? J Trauma. 2008;65(4):794–798. doi: 10.1097/TA.0b013e318184aa11. PubMed DOI

Croce MA, Tolley EA, Claridge JA, Fabian TC. Transfusions result in pulmonary morbidity and death after a moderate degree of injury. J Trauma. 2005;59(1):19–23. doi: 10.1097/01.TA.0000171459.21450.DC. PubMed DOI

Chaiwat O, Lang JD, Vavilala MS, Wang J, MacKenzie EJ, Jurkovich GJ, et al. Early packed red blood cell transfusion and acute respiratory distress syndrome after trauma. Anesthesiology. 2009;110(2):351–360. doi: 10.1097/ALN.0b013e3181948a97. PubMed DOI

Silverboard H, Aisiku I, Martin GS, Adams M, Rozycki G, Moss M. The role of acute blood transfusion in the development of acute respiratory distress syndrome in patients with severe trauma. J Trauma. 2005;59(3):717–723. PubMed

Claridge JA, Sawyer RG, Schulman AM, McLemore EC, Young JS. Blood transfusions correlate with infections in trauma patients in a dose-dependent manner. Am Surg. 2002;68(7):566–572. PubMed

Marik PE, Corwin HL. Efficacy of red blood cell transfusion in the critically ill: a systematic review of the literature. Crit Care Med. 2008;36(9):2667–2674. doi: 10.1097/CCM.0b013e3181844677. PubMed DOI

Desjardins P, Turgeon AF, Tremblay MH, Lauzier F, Zarychanski R, Boutin A, et al. Hemoglobin levels and transfusions in neurocritically ill patients: a systematic review of comparative studies. Crit Care. 2012;16(2):R54. doi: 10.1186/cc11293. PubMed DOI PMC

Bellapart J, Boots R, Fraser J. Physiopathology of anemia and transfusion thresholds in isolated head injury. J Trauma Acute Care Surg. 2012;73(4):997–1005. doi: 10.1097/TA.0b013e318265cede. PubMed DOI

Elterman J, Brasel K, Brown S, Bulger E, Christenson J, Kerby JD, et al. Transfusion of red blood cells in patients with a prehospital Glasgow Coma Scale score of 8 or less and no evidence of shock is associated with worse outcomes. J Trauma Acute Care Surg. 2013;75(1):8–14. doi: 10.1097/TA.0b013e318298492e. PubMed DOI PMC

Robertson CS, Hannay HJ, Yamal JM, Gopinath S, Goodman JC, Tilley BC, et al. Effect of erythropoietin and transfusion threshold on neurological recovery after traumatic brain injury: a randomized clinical trial. JAMA. 2014;312(1):36–47. doi: 10.1001/jama.2014.6490. PubMed DOI PMC

Peyrou V, Lormeau JC, Herault JP, Gaich C, Pfliegger AM, Herbert JM. Contribution of erythrocytes to thrombin generation in whole blood. Thromb Haemost. 1999;81(3):400–406. PubMed

Bombeli T, Spahn DR. Updates in perioperative coagulation: physiology and management of thromboembolism and haemorrhage. Br J Anaesth. 2004;93(2):275–287. doi: 10.1093/bja/aeh174. PubMed DOI

Valeri CR, Cassidy G, Pivacek LE, Ragno G, Lieberthal W, Crowley JP, et al. Anemia-induced increase in the bleeding time: implications for treatment of nonsurgical blood loss. Transfusion. 2001;41(8):977–983. doi: 10.1046/j.1537-2995.2001.41080977.x. PubMed DOI

Quaknine-Orlando B, Samama CM, Riou B, Bonnin P, Guillosson JJ, Beaumont JL, et al. Role of the hematocrit in a rabbit model of arterial thrombosis and bleeding. Anesthesiology. 1999;90(5):1454–1461. doi: 10.1097/00000542-199905000-00031. PubMed DOI

Iwata H, Kaibara M. Activation of factor IX by erythrocyte membranes causes intrinsic coagulation. Blood Coagul Fibrinolysis. 2002;13(6):489–496. doi: 10.1097/00001721-200209000-00003. PubMed DOI

Iwata H, Kaibara M, Dohmae N, Takio K, Himeno R, Kawakami S. Purification, identification, and characterization of elastase on erythrocyte membrane as factor IX-activating enzyme. Biochem Biophys Res Commun. 2004;316(1):65–70. doi: 10.1016/j.bbrc.2004.02.020. PubMed DOI

Iselin BM, Willimann PF, Seifert B, Casutt M, Bombeli T, Zalunardo MP, et al. Isolated reduction of haematocrit does not compromise in vitro blood coagulation. Br J Anaesth. 2001;87(2):246–249. doi: 10.1093/bja/87.2.246. PubMed DOI

Hobisch-Hagen P, Wiedermann F, Mayr A, Fries D, Jelkmann W, Fuchs D, et al. Blunted erythropoietic response to anemia in multiply traumatized patients. Crit Care Med. 2001;29(4):743–747. doi: 10.1097/00003246-200104000-00009. PubMed DOI

Corwin HL, Gettinger A, Pearl RG, Fink MP, Levy MM, Shapiro MJ, et al. Efficacy of recombinant human erythropoietin in critically ill patients: a randomized controlled trial. JAMA. 2002;288(22):2827–2835. doi: 10.1001/jama.288.22.2827. PubMed DOI

Corwin HL, Gettinger A, Fabian TC, May A, Pearl RG, Heard S, et al. Efficacy and safety of epoetin alfa in critically ill patients. N Engl J Med. 2007;357(10):965–976. doi: 10.1056/NEJMoa071533. PubMed DOI

Luchette FA, Pasquale MD, Fabian TC, Langholff WK, Wolfson M. A randomized, double-blind, placebo-controlled study to assess the effect of recombinant human erythropoietin on functional outcomes in anemic, critically ill, trauma subjects: the Long Term Trauma Outcomes Study. Am J Surg. 2012;203(4):508–516. doi: 10.1016/j.amjsurg.2011.08.006. PubMed DOI

Garcia-Erce JA, Cuenca J, Munoz M, Izuel M, Martinez AA, Herrera A, et al. Perioperative stimulation of erythropoiesis with intravenous iron and erythropoietin reduces transfusion requirements in patients with hip fracture. A prospective observational study. Vox Sang. 2005;88(4):235–243. doi: 10.1111/j.1423-0410.2005.00627.x. PubMed DOI

Munoz M, Gomez-Ramirez S, Cuenca J, Garcia-Erce JA, Iglesias-Aparicio D, Haman-Alcober S, et al. Very-short-term perioperative intravenous iron administration and postoperative outcome in major orthopedic surgery: a pooled analysis of observational data from 2547 patients. Transfusion. 2014;54(2):289–299. PubMed

Cuenca J, Garcia-Erce JA, Munoz M, Izuel M, Martinez AA, Herrera A. Patients with pertrochanteric hip fracture may benefit from preoperative intravenous iron therapy: a pilot study. Transfusion. 2004;44(10):1447–1452. doi: 10.1111/j.1537-2995.2004.04088.x. PubMed DOI

Prasad N, Rajamani V, Hullin D, Murray JM. Post-operative anaemia in femoral neck fracture patients: does it need treatment? A single blinded prospective randomised controlled trial. Injury. 2009;40(10):1073–1076. doi: 10.1016/j.injury.2009.02.021. PubMed DOI

Bernabeu-Wittel M, Aparicio R, Romero M, Murcia-Zaragoza J, Monte-Secades R, Rosso C, et al. Ferric carboxymaltose with or without erythropoietin for the prevention of red-cell transfusions in the perioperative period of osteoporotic hip fractures: a randomized controlled trial. The PAHFRAC-01 project. BMC Musculoskelet Disord. 2012;13:27. doi: 10.1186/1471-2474-13-27. PubMed DOI PMC

Litton E, Xiao J, Ho KM. Safety and efficacy of intravenous iron therapy in reducing requirement for allogeneic blood transfusion: systematic review and meta-analysis of randomised clinical trials. BMJ. 2013;347:f4822. doi: 10.1136/bmj.f4822. PubMed DOI PMC

Ishida JH, Marafino BJ, McCulloch CE, Dalrymple LS, Dudley RA, Grimes BA, et al. Receipt of intravenous iron and clinical outcomes among hemodialysis patients hospitalized for infection. Clin J Am Soc Nephrol. 2015;10(10):1799–1805. doi: 10.2215/CJN.01090115. PubMed DOI PMC

Heming N, Letteron P, Driss F, Millot S, El Benna J, Tourret J, et al. Efficacy and toxicity of intravenous iron in a mouse model of critical care anemia*. Crit Care Med. 2012;40(7):2141–2148. doi: 10.1097/CCM.0b013e31824e6713. PubMed DOI

Kutcher ME, Howard BM, Sperry JL, Hubbard AE, Decker AL, Cuschieri J, et al. Evolving beyond the vicious triad: differential mediation of traumatic coagulopathy by injury, shock, and resuscitation. J Trauma Acute Care Surg. 2015;78(3):516–523. doi: 10.1097/TA.0000000000000545. PubMed DOI

Watts DD, Trask A, Soeken K, Perdue P, Dols S, Kaufmann C. Hypothermic coagulopathy in trauma: effect of varying levels of hypothermia on enzyme speed, platelet function, and fibrinolytic activity. J Trauma. 1998;44(5):846–854. doi: 10.1097/00005373-199805000-00017. PubMed DOI

DeLoughery TG. Coagulation defects in trauma patients: etiology, recognition, and therapy. Crit Care Clin. 2004;20(1):13–24. doi: 10.1016/S0749-0704(03)00089-7. PubMed DOI

Bernabei AF, Levison MA, Bender JS. The effects of hypothermia and injury severity on blood loss during trauma laparotomy. J Trauma. 1992;33(6):835–839. doi: 10.1097/00005373-199212000-00007. PubMed DOI

Hoey BA, Schwab CW. Damage control surgery. Scand J Surg. 2002;91(1):92–103. PubMed

Reynolds BR, Forsythe RM, Harbrecht BG, Cuschieri J, Minei JP, Maier RV, et al. Hypothermia in massive transfusion: have we been paying enough attention to it? J Trauma Acute Care Surg. 2012;73(2):486–491. doi: 10.1097/TA.0b013e31825c163b. PubMed DOI

Rubiano AM, Sanchez AI, Estebanez G, Peitzman A, Sperry J, Puyana JC. The effect of admission spontaneous hypothermia on patients with severe traumatic brain injury. Injury. 2013;44(9):1219–1225. doi: 10.1016/j.injury.2012.11.026. PubMed DOI PMC

Eddy VA, Morris JA, Jr, Cullinane DC. Hypothermia, coagulopathy, and acidosis. Surg Clin North Am. 2000;80(3):845–854. doi: 10.1016/S0039-6109(05)70099-2. PubMed DOI

Watts DD, Roche M, Tricarico R, Poole F, Brown JJ, Jr, Colson GB, et al. The utility of traditional prehospital interventions in maintaining thermostasis. Prehosp Emerg Care. 1999;3(2):115–122. doi: 10.1080/10903129908958918. PubMed DOI

Barthel ER, Pierce JR. Steady-state and time-dependent thermodynamic modeling of the effect of intravenous infusion of warm and cold fluids. J Trauma Acute Care Surg. 2012;72(6):1590–1600. doi: 10.1097/TA.0b013e31824a7943. PubMed DOI

Clifton GL, Choi SC, Miller ER, Levin HS, Smith KR, Jr, Muizelaar JP, et al. Intercenter variance in clinical trials of head trauma--experience of the National Acute Brain Injury Study: Hypothermia. J Neurosurg. 2001;95(5):751–755. doi: 10.3171/jns.2001.95.5.0751. PubMed DOI

Clifton GL, Valadka A, Zygun D, Coffey CS, Drever P, Fourwinds S, et al. Very early hypothermia induction in patients with severe brain injury (the National Acute Brain Injury Study: Hypothermia II): a randomised trial. Lancet Neurol. 2011;10(2):131–139. doi: 10.1016/S1474-4422(10)70300-8. PubMed DOI PMC

Maekawa T, Yamashita S, Nagao S, Hayashi N, Ohashi Y. Prolonged mild therapeutic hypothermia versus fever control with tight hemodynamic monitoring and slow rewarming in patients with severe traumatic brain injury: a randomized controlled trial. J Neurotrauma. 2015;32(7):422–429. doi: 10.1089/neu.2013.3197. PubMed DOI PMC

Crossley S, Reid J, McLatchie R, Hayton J, Clark C, MacDougall M, et al. A systematic review of therapeutic hypothermia for adult patients following traumatic brain injury. Crit Care. 2014;18(2):R75. doi: 10.1186/cc13835. PubMed DOI PMC

Sadaka F, Veremakis C. Therapeutic hypothermia for the management of intracranial hypertension in severe traumatic brain injury: a systematic review. Brain Inj. 2012;26(7–8):899–908. doi: 10.3109/02699052.2012.661120. PubMed DOI

Georgiou AP, Manara AR. Role of therapeutic hypothermia in improving outcome after traumatic brain injury: a systematic review. Br J Anaesth. 2013;110(3):357–367. doi: 10.1093/bja/aes500. PubMed DOI

Polderman KH, van Zanten AR, Nipshagen MD, Girbes AR. Induced hypothermia in traumatic brain injury: effective if properly employed. Crit Care Med. 2004;32(1):313–314. doi: 10.1097/01.CCM.0000104936.28288.7A. PubMed DOI

Jiang JY, Xu W, Li WP, Gao GY, Bao YH, Liang YM, et al. Effect of long-term mild hypothermia or short-term mild hypothermia on outcome of patients with severe traumatic brain injury. J Cereb Blood Flow Metab. 2006;26(6):771–776. doi: 10.1038/sj.jcbfm.9600253. PubMed DOI

Stone HH, Strom PR, Mullins RJ. Management of the major coagulopathy with onset during laparotomy. Ann Surg. 1983;197(5):532–535. doi: 10.1097/00000658-198305000-00005. PubMed DOI PMC

Morris JA, Jr, Eddy VA, Blinman TA, Rutherford EJ, Sharp KW. The staged celiotomy for trauma. Issues in unpacking and reconstruction. Ann Surg. 1993;217(5):576–584. doi: 10.1097/00000658-199305010-00019. PubMed DOI PMC

Rotondo MF, Schwab CW, McGonigal MD, Phillips GR, 3rd, Fruchterman TM, Kauder DR, et al. ‘Damage control’: an approach for improved survival in exsanguinating penetrating abdominal injury. J Trauma. 1993;35(3):375–382. doi: 10.1097/00005373-199309000-00008. PubMed DOI

Hirshberg A, Dugas M, Banez EI, Scott BG, Wall MJ, Jr, Mattox KL. Minimizing dilutional coagulopathy in exsanguinating hemorrhage: a computer simulation. J Trauma. 2003;54(3):454–463. doi: 10.1097/01.TA.0000053245.08642.1F. PubMed DOI

Shapiro MB, Jenkins DH, Schwab CW, Rotondo MF. Damage control: collective review. J Trauma. 2000;49(5):969–978. doi: 10.1097/00005373-200011000-00033. PubMed DOI

Asensio JA, McDuffie L, Petrone P, Roldan G, Forno W, Gambaro E, et al. Reliable variables in the exsanguinated patient which indicate damage control and predict outcome. Am J Surg. 2001;182(6):743–751. doi: 10.1016/S0002-9610(01)00809-1. PubMed DOI

Moore EE, Burch JM, Franciose RJ, Offner PJ, Biffl WL. Staged physiologic restoration and damage control surgery. World J Surg. 1998;22(12):1184–1190. doi: 10.1007/s002689900542. PubMed DOI

Braslow B. Damage control in abdominal trauma. Contemp Surgery. 2006;62:65–74.

Hsu JM, Pham TN. Damage control in the injured patient. Int J Crit Illn Inj Sci. 2011;1(1):66–72. doi: 10.4103/2229-5151.79285. PubMed DOI PMC

Scalea TM, Boswell SA, Scott JD, Mitchell KA, Kramer ME, Pollak AN. External fixation as a bridge to intramedullary nailing for patients with multiple injuries and with femur fractures: damage control orthopedics. J Trauma. 2000;48(4):613–621. doi: 10.1097/00005373-200004000-00006. PubMed DOI

Pape HC, Rixen D, Morley J, Husebye EE, Mueller M, Dumont C, et al. Impact of the method of initial stabilization for femoral shaft fractures in patients with multiple injuries at risk for complications (borderline patients) Ann Surg. 2007;246(3):491–499. doi: 10.1097/SLA.0b013e3181485750. PubMed DOI PMC

Caba-Doussoux P, Leon-Baltasar JL, Garcia-Fuentes C, Resines-Erasun C. Damage control orthopaedics in severe polytrauma with femur fracture. Injury. 2012;43(Suppl 2):S42–S46. doi: 10.1016/S0020-1383(13)70178-5. PubMed DOI

Wall MJ, Jr, Soltero E. Damage control for thoracic injuries. Surg Clin North Am. 1997;77(4):863–878. doi: 10.1016/S0039-6109(05)70590-9. PubMed DOI

Rosenfeld JV. Damage control neurosurgery. Injury. 2004;35(7):655–660. doi: 10.1016/j.injury.2004.03.006. PubMed DOI

Ertel W, Keel M, Eid K, Platz A, Trentz O. Control of severe hemorrhage using C-clamp and pelvic packing in multiply injured patients with pelvic ring disruption. J Orthop Trauma. 2001;15(7):468–474. doi: 10.1097/00005131-200109000-00002. PubMed DOI

Brenner M, Hoehn M, Rasmussen TE. Endovascular therapy in trauma. Eur J Trauma Emerg Surg. 2014;40(6):671–678. PubMed

Hagiwara A, Minakawa K, Fukushima H, Murata A, Masuda H, Shimazaki S. Predictors of death in patients with life-threatening pelvic hemorrhage after successful transcatheter arterial embolization. J Trauma. 2003;55(4):696–703. doi: 10.1097/01.TA.0000053384.85091.C6. PubMed DOI

Verbeek DO, Zijlstra IA, van der Leij C, Ponsen KJ, van Delden OM, Goslings JC. Management of pelvic ring fracture patients with a pelvic “blush” on early computed tomography. J Trauma Acute Care Surg. 2014;76(2):374–379. doi: 10.1097/TA.0000000000000094. PubMed DOI

Verbeek DO, Zijlstra IA, van der Leij C, Ponsen KJ, van Delden OM, Goslings JC. Predicting the need for abdominal hemorrhage control in major pelvic fracture patients: the importance of quantifying the amount of free fluid. J Trauma Acute Care Surg. 2014;76(5):1259–1263. doi: 10.1097/TA.0000000000000201. PubMed DOI

Toth L, King KL, McGrath B, Balogh ZJ. Efficacy and safety of emergency non-invasive pelvic ring stabilisation. Injury. 2012;43(8):1330–1334. doi: 10.1016/j.injury.2012.05.014. PubMed DOI

Tiemann AH, Schmidt C, Gonschorek O, Josten C. Use of the “c-clamp” in the emergency treatment of unstable pelvic fractures. Zentralbl Chir. 2004;129(4):245–251. doi: 10.1055/s-2004-822833. PubMed DOI

Totterman A, Madsen JE, Skaga NO, Roise O. Extraperitoneal pelvic packing: a salvage procedure to control massive traumatic pelvic hemorrhage. J Trauma. 2007;62(4):843–852. doi: 10.1097/01.ta.0000221673.98117.c9. PubMed DOI

Smith WR, Moore EE, Osborn P, Agudelo JF, Morgan SJ, Parekh AA, et al. Retroperitoneal packing as a resuscitation technique for hemodynamically unstable patients with pelvic fractures: report of two representative cases and a description of technique. J Trauma. 2005;59(6):1510–1514. doi: 10.1097/01.ta.0000197330.81352.94. PubMed DOI

Osborn PM, Smith WR, Moore EE, Cothren CC, Morgan SJ, Williams AE, et al. Direct retroperitoneal pelvic packing versus pelvic angiography: a comparison of two management protocols for haemodynamically unstable pelvic fractures. Injury. 2009;40(1):54–60. doi: 10.1016/j.injury.2008.08.038. PubMed DOI

Michailidou M, Velmahos GC, van der Wilden GM, Alam HB, de Moya M, Chang Y. “Blush” on trauma computed tomography: not as bad as we think! J Trauma Acute Care Surg. 2012;73(3):580–584. doi: 10.1097/TA.0b013e318265cbd4. PubMed DOI

Verbeek D, Sugrue M, Balogh Z, Cass D, Civil I, Harris I, et al. Acute management of hemodynamically unstable pelvic trauma patients: time for a change? Multicenter review of recent practice. World J Surg. 2008;32(8):1874–1882. doi: 10.1007/s00268-008-9591-z. PubMed DOI

Tanizaki S, Maeda S, Matano H, Sera M, Nagai H, Ishida H. Time to pelvic embolization for hemodynamically unstable pelvic fractures may affect the survival for delays up to 60 min. Injury. 2014;45(4):738–741. doi: 10.1016/j.injury.2013.11.007. PubMed DOI

Geeraerts T, Chhor V, Cheisson G, Martin L, Bessoud B, Ozanne A, et al. Clinical review: initial management of blunt pelvic trauma patients with haemodynamic instability. Crit Care. 2007;11(1):204. doi: 10.1186/cc5157. PubMed DOI PMC

van der Vlies CH, Saltzherr TP, Reekers JA, Ponsen KJ, van Delden OM, Goslings JC. Failure rate and complications of angiography and embolization for abdominal and pelvic trauma. J Trauma Acute Care Surg. 2012;73(5):1208–1212. doi: 10.1097/TA.0b013e318265ca9f. PubMed DOI

Banerjee A, Duane TM, Wilson SP, Haney S, O’Neill PJ, Evans HL, et al. Trauma center variation in splenic artery embolization and spleen salvage: a multicenter analysis. J Trauma Acute Care Surg. 2013;75(1):69–74. doi: 10.1097/TA.0b013e3182988b3b. PubMed DOI

Wang YC, Fu CY, Chen YF, Hsieh CH, Wu SC, Yeh CC. Role of arterial embolization on blunt hepatic trauma patients with type I contrast extravasation. Am J Emerg Med. 2011;29(9):1147–1151. doi: 10.1016/j.ajem.2010.06.001. PubMed DOI

Hagiwara A, Sakaki S, Goto H, Takenega K, Fukushima H, Matuda H, et al. The role of interventional radiology in the management of blunt renal injury: a practical protocol. J Trauma. 2001;51(3):526–531. doi: 10.1097/00005373-200109000-00017. PubMed DOI

Hagiwara A, Yanagawa Y, Kaneko N, Takasu A, Hatanaka K, Sakamoto T, et al. Indications for transcatheter arterial embolization in persistent hemothorax caused by blunt trauma. J Trauma. 2008;65(3):589–594. doi: 10.1097/TA.0b013e318181d56a. PubMed DOI

Nemoto C, Ikegami Y, Suzuki T, Tsukada Y, Abe Y, Shimada J, et al. Repeated embolization of intercostal arteries after blunt chest injury. Gen Thorac Cardiovasc Surg. 2014;62(11):696–699. doi: 10.1007/s11748-013-0269-6. PubMed DOI

Martinelli T, Thony F, Declety P, Sengel C, Broux C, Tonetti J, et al. Intra-aortic balloon occlusion to salvage patients with life-threatening hemorrhagic shocks from pelvic fractures. J Trauma. 2010;68(4):942–948. PubMed

Morozumi J, Homma H, Ohta S, Noda M, Oda J, Mishima S, et al. Impact of mobile angiography in the emergency department for controlling pelvic fracture hemorrhage with hemodynamic instability. J Trauma. 2010;68(1):90–95. doi: 10.1097/TA.0b013e3181c40061. PubMed DOI

Brenner ML, Moore LJ, DuBose JJ, Tyson GH, McNutt MK, Albarado RP, et al. A clinical series of resuscitative endovascular balloon occlusion of the aorta for hemorrhage control and resuscitation. J Trauma Acute Care Surg. 2013;75(3):506–511. doi: 10.1097/TA.0b013e31829e5416. PubMed DOI

Seyednejad H, Imani M, Jamieson T, Seifalian AM. Topical haemostatic agents. Br J Surg. 2008;95(10):1197–1225. doi: 10.1002/bjs.6357. PubMed DOI

Recinos G, Inaba K, Dubose J, Demetriades D, Rhee P. Local and systemic hemostatics in trauma: a review. Ulus Travma Acil Cerrahi Derg. 2008;14(3):175–181. PubMed

Woodworth BA, Chandra RK, LeBenger JD, Ilie B, Schlosser RJ. A gelatin-thrombin matrix for hemostasis after endoscopic sinus surgery. Am J Otolaryngol. 2009;30(1):49–53. doi: 10.1016/j.amjoto.2007.11.008. PubMed DOI

Testini M, Marzaioli R, Lissidini G, Lippolis A, Logoluso F, Gurrado A, et al. The effectiveness of FloSeal matrix hemostatic agent in thyroid surgery: a prospective, randomized, control study. Langenbecks Arch Surg. 2009;394(5):837–842. doi: 10.1007/s00423-009-0497-5. PubMed DOI

Pursifull NF, Morris MS, Harris RA, Morey AF. Damage control management of experimental grade 5 renal injuries: further evaluation of FloSeal gelatin matrix. J Trauma. 2006;60(2):346–350. doi: 10.1097/01.ta.0000202514.96964.85. PubMed DOI

Weaver FA, Hood DB, Zatina M, Messina L, Badduke B. Gelatin-thrombin-based hemostatic sealant for intraoperative bleeding in vascular surgery. Ann Vasc Surg. 2002;16(3):286–293. doi: 10.1007/s10016-001-0073-0. PubMed DOI

Oz MC, Cosgrove DM, 3rd, Badduke BR, Hill JD, Flannery MR, Palumbo R, et al. Controlled clinical trial of a novel hemostatic agent in cardiac surgery. The Fusion Matrix Study Group. Ann Thorac Surg. 2000;69(5):1376–1382. doi: 10.1016/S0003-4975(00)01194-2. PubMed DOI

Sherman R, Chapman WC, Hannon G, Block JE. Control of bone bleeding at the sternum and iliac crest donor sites using a collagen-based composite combined with autologous plasma: results of a randomized controlled trial. Orthopedics. 2001;24(2):137–141. PubMed

Chapman WC, Clavien PA, Fung J, Khanna A, Bonham A. Effective control of hepatic bleeding with a novel collagen-based composite combined with autologous plasma: results of a randomized controlled trial. Arch Surg. 2000;135(10):1200–1204. doi: 10.1001/archsurg.135.10.1200. PubMed DOI

Smith KJ, Skelton HG, Barrett TL, Welch M, Beard J. Histologic and immunohistochemical features in biopsy sites in which bovine collagen matrix was used for hemostasis. J Am Acad Dermatol. 1996;34(3):434–438. doi: 10.1016/S0190-9622(96)90435-1. PubMed DOI

CoStasis Multi-center Collaborative Writing Committee: A novel collagen-based composite offers effective hemostasis for multiple surgical indications: Results of a randomized controlled trial. Surgery. 2001;129(4):445-50. PubMed

Drake DB, Wong LG. Hemostatic effect of Vivostat patient-derived fibrin sealant on split-thickness skin graft donor sites. Ann Plast Surg. 2003;50(4):367–372. doi: 10.1097/01.SAP.0000041484.22953.6D. PubMed DOI

Molloy DO, Archbold HA, Ogonda L, McConway J, Wilson RK, Beverland DE. Comparison of topical fibrin spray and tranexamic acid on blood loss after total knee replacement: a prospective, randomised controlled trial. J Bone Joint Surg (Br) 2007;89(3):306–309. doi: 10.1302/0301-620X.89B3.17565. PubMed DOI

Schenk WG, 3rd, Burks SG, Gagne PJ, Kagan SA, Lawson JH, Spotnitz WD. Fibrin sealant improves hemostasis in peripheral vascular surgery: a randomized prospective trial. Ann Surg. 2003;237(6):871–876. PubMed PMC

Ollinger R, Mihaljevic AL, Schuhmacher C, Bektas H, Vondran F, Kleine M, et al. A multicentre, randomized clinical trial comparing the Veriset™ haemostatic patch with fibrin sealant for the management of bleeding during hepatic surgery. HPB (Oxford) 2013;15(7):548–558. doi: 10.1111/hpb.12009. PubMed DOI PMC

Witte B, Kroeber SM, Hillebrand H, Wolf M, Huertgen M. Cotton-derived oxidized cellulose in minimally invasive thoracic surgery: a clinicopathological study. Innovations (Phila) 2013;8(4):296–301. doi: 10.1097/IMI.0b013e3182a6afcf. PubMed DOI

King DR, Cohn SM, Proctor KG, Miami Clinical Trials Group Modified rapid deployment hemostat bandage terminates bleeding in coagulopathic patients with severe visceral injuries. J Trauma. 2004;57(4):756–759. doi: 10.1097/01.TA.0000147501.64610.AFS. PubMed DOI

White NJ, Contaifer D, Jr, Martin EJ, Newton JC, Mohammed BM, Bostic JL, et al. Early hemostatic responses to trauma identified with hierarchical clustering analysis. J Thromb Haemost. 2015;13(6):978–988. doi: 10.1111/jth.12919. PubMed DOI PMC

Schochl H, Voelckel W, Maegele M, Kirchmair L, Schlimp CJ. Endogenous thrombin potential following hemostatic therapy with 4-factor prothrombin complex concentrate: a 7-day observational study of trauma patients. Crit Care. 2014;18(4):R147. doi: 10.1186/cc13982. PubMed DOI PMC

Cardenas JC, Rahbar E, Pommerening MJ, Baer LA, Matijevic N, Cotton BA, et al. Measuring thrombin generation as a tool for predicting hemostatic potential and transfusion requirements following trauma. J Trauma Acute Care Surg. 2014;77(6):839–845. doi: 10.1097/TA.0000000000000348. PubMed DOI

Spahn DR. TEG(R)- or ROTEM(R)-based individualized goal-directed coagulation algorithms: don’t wait--act now! Crit Care. 2014;18(6):637. doi: 10.1186/s13054-014-0637-3. PubMed DOI PMC

Brenni M, Worn M, Bruesch M, Spahn DR, Ganter MT. Successful rotational thromboelastometry-guided treatment of traumatic haemorrhage, hyperfibrinolysis and coagulopathy. Acta Anaesthesiol Scand. 2010;54(1):111–117. doi: 10.1111/j.1399-6576.2009.02132.x. PubMed DOI

Kashuk JL, Moore EE, Johnson JL, Haenel J, Wilson M, Moore JB, et al. Postinjury life threatening coagulopathy: is 1:1 fresh frozen plasma:packed red blood cells the answer? J Trauma. 2008;65(2):261–270. doi: 10.1097/TA.0b013e31817de3e1. PubMed DOI

Nienaber U, Innerhofer P, Westermann I, Schöchl H, Attal R, Breitkopf R, et al. The impact of fresh frozen plasma vs coagulation factor concentrates on morbidity and mortality in trauma-associated haemorrhage and massive transfusion. Injury. 2011;42(7):697–701. doi: 10.1016/j.injury.2010.12.015. PubMed DOI

Riskin DJ, Tsai TC, Riskin L, Hernandez-Boussard T, Purtill M, Maggio PM, et al. Massive transfusion protocols: the role of aggressive resuscitation versus product ratio in mortality reduction. J Am Coll Surg. 2009;209(2):198–205. doi: 10.1016/j.jamcollsurg.2009.04.016. PubMed DOI

Schöchl H, Nienaber U, Hofer G, Voelckel W, Jambor C, Scharbert G, et al. Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate. Crit Care. 2010;14(2):R55. doi: 10.1186/cc8948. PubMed DOI PMC

Weber CF, Gorlinger K, Meininger D, Herrmann E, Bingold T, Moritz A, et al. Point-of-care testing: a prospective, randomized clinical trial of efficacy in coagulopathic cardiac surgery patients. Anesthesiology. 2012;117(3):531–547. doi: 10.1097/ALN.0b013e318264c644. PubMed DOI

Nakayama Y, Nakajima Y, Tanaka KA, Sessler DI, Maeda S, Iida J, et al. Thromboelastometry-guided intraoperative haemostatic management reduces bleeding and red cell transfusion after paediatric cardiac surgery. Br J Anaesth. 2015;114(1):91–102. doi: 10.1093/bja/aeu339. PubMed DOI

Karkouti K, McCluskey SA, Callum J, Freedman J, Selby R, Timoumi T, et al. Evaluation of a novel transfusion algorithm employing point-of-care coagulation assays in cardiac surgery: a retrospective cohort study with interrupted time-series analysis. Anesthesiology. 2015;122(3):560–570. doi: 10.1097/ALN.0000000000000556. PubMed DOI

Cotton BA, Au BK, Nunez TC, Gunter OL, Robertson AM, Young PP. Predefined massive transfusion protocols are associated with a reduction in organ failure and postinjury complications. J Trauma. 2009;66(1):41–48. doi: 10.1097/TA.0b013e31819313bb. PubMed DOI

Maciel JD, Gifford E, Plurad D, de Virgilio C, Bricker S, Bongard F, et al. The impact of a massive transfusion protocol on outcomes among patients with abdominal aortic injuries. Ann Vasc Surg. 2015;29(4):764–769. doi: 10.1016/j.avsg.2014.11.024. PubMed DOI

Nascimento B, Callum J, Tien H, Rubenfeld G, Pinto R, Lin Y, et al. Effect of a fixed-ratio (1:1:1) transfusion protocol versus laboratory-results-guided transfusion in patients with severe trauma: a randomized feasibility trial. CMAJ. 2013;185(12):E583–E589. doi: 10.1503/cmaj.121986. PubMed DOI PMC

Nardi G, Agostini V, Rondinelli B, Russo E, Bastianini B, Bini G, et al. Trauma-induced coagulopathy: impact of the early coagulation support protocol on blood product consumption, mortality and costs. Crit Care. 2015;19(1):83. doi: 10.1186/s13054-015-0817-9. PubMed DOI PMC

Scalea TM, Bochicchio KM, Lumpkins K, Hess JR, Dutton R, Pyle A, et al. Early aggressive use of fresh frozen plasma does not improve outcome in critically injured trauma patients. Ann Surg. 2008;248(4):578–584. PubMed

Hendrickson JE, Shaz BH, Pereira G, Parker PM, Jessup P, Atwell F, et al. Implementation of a pediatric trauma massive transfusion protocol: one institution’s experience. Transfusion. 2012;52(6):1228–1236. doi: 10.1111/j.1537-2995.2011.03458.x. PubMed DOI

Kelly JM, Callum JL, Rizoli SB. 1:1:1 - Warranted or wasteful? Even where appropriate, high ratio transfusion protocols are costly: early transition to individualized care benefits patients and transfusion services. Expert Rev Hematol. 2013;6(6):631–633. doi: 10.1586/17474086.2013.859520. PubMed DOI

Holcomb JB, Jenkins D, Rhee P, Johannigman J, Mahoney P, Mehta S, et al. Damage control resuscitation: directly addressing the early coagulopathy of trauma. J Trauma. 2007;62(2):307–310. doi: 10.1097/TA.0b013e3180324124. PubMed DOI

Ketchum L, Hess JR, Hiippala S. Indications for early fresh frozen plasma, cryoprecipitate, and platelet transfusion in trauma. J Trauma. 2006;60(6 Suppl):S51–S58. doi: 10.1097/01.ta.0000199432.88847.0c. PubMed DOI

Holcomb JB, Hess JR. Early massive trauma transfusion: state of the art: editor’s introduction. J Trauma Acute Care Surg. 2006;60(6):S1–S2. doi: 10.1097/01.ta.0000199638.50985.c7. DOI

Dente CJ, Shaz BH, Nicholas JM, Harris RS, Wyrzykowski AD, Patel S, et al. Improvements in early mortality and coagulopathy are sustained better in patients with blunt trauma after institution of a massive transfusion protocol in a civilian level I trauma center. J Trauma. 2009;66(6):1616–1624. doi: 10.1097/TA.0b013e3181a59ad5. PubMed DOI

Savage SA, Zarzaur BL, Croce MA, Fabian TC. Time matters in 1: 1 resuscitations: concurrent administration of blood: plasma and risk of death. J Trauma Acute Care Surg. 2014;77(6):833–837. doi: 10.1097/TA.0000000000000355. PubMed DOI

Snyder CW, Weinberg JA, McGwin G, Jr, Melton SM, George RL, Reiff DA, et al. The relationship of blood product ratio to mortality: survival benefit or survival bias? J Trauma. 2009;66(2):358–362. doi: 10.1097/TA.0b013e318196c3ac. PubMed DOI

Ho AM, Dion PW, Yeung JH, Holcomb JB, Critchley LA, Ng CS, et al. Prevalence of survivor bias in observational studies on fresh frozen plasma:erythrocyte ratios in trauma requiring massive transfusion. Anesthesiology. 2012;116(3):716–728. doi: 10.1097/ALN.0b013e318245c47b. PubMed DOI

Khan S, Brohi K, Chana M, Raza I, Stanworth S, Gaarder C, et al. Hemostatic resuscitation is neither hemostatic nor resuscitative in trauma hemorrhage. J Trauma Acute Care Surg. 2014;76(3):561–567. doi: 10.1097/TA.0000000000000146. PubMed DOI

Holcomb JB, Tilley BC, Baraniuk S, Fox EE, Wade CE, Podbielski JM, et al. Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial. JAMA. 2015;313(5):471–482. doi: 10.1001/jama.2015.12. PubMed DOI PMC

Baraniuk S, Tilley BC, del Junco DJ, Fox EE, van Belle G, Wade CE, et al. Pragmatic Randomized Optimal Platelet and Plasma Ratios (PROPPR) Trial: design, rationale and implementation. Injury. 2014;45(9):1287–1295. doi: 10.1016/j.injury.2014.06.001. PubMed DOI PMC

Toy P, Popovsky MA, Abraham E, Ambruso DR, Holness LG, Kopko PM, et al. Transfusion-related acute lung injury: definition and review. Crit Care Med. 2005;33(4):721–726. doi: 10.1097/01.CCM.0000159849.94750.51. PubMed DOI

Holness L, Knippen MA, Simmons L, Lachenbruch PA. Fatalities caused by TRALI. Transfus Med Rev. 2004;18(3):184–188. doi: 10.1016/j.tmrv.2004.03.004. PubMed DOI

Pandey S, Vyas GN. Adverse effects of plasma transfusion. Transfusion. 2012;52(Suppl 1):65S–79S. doi: 10.1111/j.1537-2995.2012.03663.x. PubMed DOI PMC

Rourke C, Curry N, Khan S, Taylor R, Raza I, Davenport R, et al. Fibrinogen levels during trauma hemorrhage, response to replacement therapy, and association with patient outcomes. J Thromb Haemost. 2012;10(7):1342–1351. doi: 10.1111/j.1538-7836.2012.04752.x. PubMed DOI

Stinger HK, Spinella PC, Perkins JG, Grathwohl KW, Salinas J, Martini WZ, et al. The ratio of fibrinogen to red cells transfused affects survival in casualties receiving massive transfusions at an army combat support hospital. J Trauma. 2008;64(2 Suppl):S79–S85. doi: 10.1097/TA.0b013e318160a57b. PubMed DOI

Nardi G, Agostini V, Rondinelli BM, Bocci G, Di Bartolomeo S, Bini G, et al. Prevention and treatment of trauma induced coagulopathy (TIC). An intended protocol from the Italian trauma update research group. J Anesth Clin Sci. 2013;2:22. doi: 10.7243/2049-9752-2-22. DOI

Zentai C, Braunschweig T, Schnabel J, Rose M, Rossaint R, Grottke O. Fibrinogen concentrate does not suppress endogenous fibrinogen synthesis in a 24-hour porcine trauma model. Anesthesiology. 2014;121(4):753–764. doi: 10.1097/ALN.0000000000000315. PubMed DOI

Chowdary P, Saayman AG, Paulus U, Findlay GP, Collins PW. Efficacy of standard dose and 30 ml/kg fresh frozen plasma in correcting laboratory parameters of haemostasis in critically ill patients. Br J Haematol. 2004;125(1):69–73. doi: 10.1111/j.1365-2141.2004.04868.x. PubMed DOI

Halmin M, Bostrom F, Brattstrom O, Lundahl J, Wikman A, Ostlund A, et al. Effect of plasma-to-RBC ratios in trauma patients: a cohort study with time-dependent data*. Crit Care Med. 2013;41(8):1905–1914. doi: 10.1097/CCM.0b013e31828a3214. PubMed DOI

McCormack PL. Tranexamic acid: a review of its use in the treatment of hyperfibrinolysis. Drugs. 2012;72(5):585–617. doi: 10.2165/11209070-000000000-00000. PubMed DOI

Shakur H, Roberts I, Bautista R, Caballero J, Coats T, Dewan Y, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet. 2010;376(9734):23–32. doi: 10.1016/S0140-6736(10)60835-5. PubMed DOI

Roberts I, Shakur H, Ker K, Coats T, Collaborators C-T. Antifibrinolytic drugs for acute traumatic injury. Cochrane Database Syst Rev. 2012;12:CD004896. PubMed

Roberts I, Prieto-Merino D, Manno D. Mechanism of action of tranexamic acid in bleeding trauma patients: an exploratory analysis of data from the CRASH-2 trial. Crit Care. 2014;18(6):685. doi: 10.1186/s13054-014-0685-8. PubMed DOI PMC

Harvin JA, Peirce CA, Mims MM, Hudson JA, Podbielski JM, Wade CE, et al. The impact of tranexamic acid on mortality in injured patients with hyperfibrinolysis. J Trauma Acute Care Surg. 2015;78(5):905–911. doi: 10.1097/TA.0000000000000612. PubMed DOI

Cole E, Davenport R, Willett K, Brohi K. Tranexamic acid use in severely injured civilian patients and the effects on outcomes: a prospective cohort study. Ann Surg. 2015;261(2):390–394. doi: 10.1097/SLA.0000000000000717. PubMed DOI

Kalavrouziotis D, Voisine P, Mohammadi S, Dionne S, Dagenais F. High-dose tranexamic acid is an independent predictor of early seizure after cardiopulmonary bypass. Ann Thorac Surg. 2012;93(1):148–154. doi: 10.1016/j.athoracsur.2011.07.085. PubMed DOI

Roberts I, Shakur H, Afolabi A, Brohi K, Coats T, Dewan Y, et al. The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet. 2011;377(9771):1096–1101. doi: 10.1016/S0140-6736(11)60317-6. PubMed DOI

Roberts I, Perel P, Prieto-Merino D, Shakur H, Coats T, Hunt BJ, et al. Effect of tranexamic acid on mortality in patients with traumatic bleeding: prespecified analysis of data from randomised controlled trial. BMJ. 2012;345:e5839. doi: 10.1136/bmj.e5839. PubMed DOI PMC

Guerriero C, Cairns J, Perel P, Shakur H, Roberts I. Cost-effectiveness analysis of administering tranexamic acid to bleeding trauma patients using evidence from the CRASH-2 trial. PLoS One. 2011;6(5):e18987. doi: 10.1371/journal.pone.0018987. PubMed DOI PMC

Roberts I, Shakur H, Coats T, Hunt B, Balogun E, Barnetson L, et al. The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients. Health Technol Assess. 2013;17(10):1–79. doi: 10.3310/hta17100. PubMed DOI PMC

Fergusson DA, Hebert PC, Mazer CD, Fremes S, MacAdams C, Murkin JM, et al. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med. 2008;358(22):2319–2331. doi: 10.1056/NEJMoa0802395. PubMed DOI

Furie B, Furie BC. Mechanisms of thrombus formation. N Engl J Med. 2008;359(9):938–949. doi: 10.1056/NEJMra0801082. PubMed DOI

Hiippala ST, Myllyla GJ, Vahtera EM. Hemostatic factors and replacement of major blood loss with plasma-poor red cell concentrates. Anesth Analg. 1995;81(2):360–365. PubMed

Charbit B, Mandelbrot L, Samain E, Baron G, Haddaoui B, Keita H, et al. The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. J Thromb Haemost. 2007;5(2):266–273. doi: 10.1111/j.1538-7836.2007.02297.x. PubMed DOI

Shaz BH, Dente CJ, Nicholas J, MacLeod JB, Young AN, Easley K, et al. Increased number of coagulation products in relationship to red blood cell products transfused improves mortality in trauma patients. Transfusion. 2010;50(2):493–500. doi: 10.1111/j.1537-2995.2009.02414.x. PubMed DOI

Meyer MA, Ostrowski SR, Windeløv NA, Johansson PI. Fibrinogen concentrates for bleeding trauma patients: what is the evidence? Vox Sang. 2011;101(3):185–190. doi: 10.1111/j.1423-0410.2011.01478.x. PubMed DOI

Kozek-Langenecker SA, Afshari A, Albaladejo P, Santullano CA, De Robertis E, Filipescu DC, et al. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol. 2013;30(6):270–382. doi: 10.1097/EJA.0b013e32835f4d5b. PubMed DOI

Gorlinger K, Fries D, Dirkmann D, Weber CF, Hanke AA, Schochl H. Reduction of fresh frozen plasma requirements by perioperative point-of-care coagulation management with early calculated goal-directed therapy. Transfus Med Hemother. 2012;39(2):104–113. doi: 10.1159/000337186. PubMed DOI PMC

Morrison JJ, Ross JD, Dubose JJ, Jansen JO, Midwinter MJ, Rasmussen TE. Association of cryoprecipitate and tranexamic acid with improved survival following wartime injury: findings from the MATTERs II Study. JAMA Surg. 2013;148(3):218–225. doi: 10.1001/jamasurg.2013.764. PubMed DOI

Holcomb JB, Fox EE, Zhang X, White N, Wade CE, Cotton BA, et al. Cryoprecipitate use in the PROMMTT study. J Trauma Acute Care Surg. 2013;75(1 Suppl 1):S31–S39. doi: 10.1097/TA.0b013e31828fa3ed. PubMed DOI PMC

Curry N, Rourke C, Davenport R, Beer S, Pankhurst L, Deary A, et al. Early cryoprecipitate for major haemorrhage in trauma: a randomised controlled feasibility trial. Br J Anaesth. 2015;115(1):76–83. doi: 10.1093/bja/aev134. PubMed DOI

Weinstock N, Ntefidou M. ISTH/SSC Subcommittee, GTH Fibrogen Working Party. SSC International Collaborative Study to establish the first high fibrinogen plasma reference material for use with different fibrinogen assay techniques. J Thromb Haemost. 2006;4(8):1825–1827. doi: 10.1111/j.1538-7836.2006.02049.x. PubMed DOI

Mackie IJ, Kitchen S, Machin SJ, Lowe GD, Haemostasis and Thrombosis Task Force of the British Committee for Standards in Haematology Guidelines on fibrinogen assays. Br J Haematol. 2003;121(3):396–404. doi: 10.1046/j.1365-2141.2003.04256.x. PubMed DOI

Solomon C, Rahe-Meyer N, Schochl H, Ranucci M, Gorlinger K. Effect of haematocrit on fibrin-based clot firmness in the FIBTEM test. Blood Transfus. 2013;11(3):412–418. PubMed PMC

Schlimp CJ, Cadamuro J, Solomon C, Redl H, Schochl H. The effect of fibrinogen concentrate and factor XIII on thromboelastometry in 33 % diluted blood with albumin, gelatine, hydroxyethyl starch or saline in vitro. Blood Transfus. 2013;11(4):510–517. PubMed PMC

Thompson GH, Florentino-Pineda I, Armstrong DG, Poe-Kochert C. Fibrinogen levels following Amicar in surgery for idiopathic scoliosis. Spine (Phila Pa 1976) 2007;32(3):368–372. doi: 10.1097/01.brs.0000253962.24179.bc. PubMed DOI

Wei KL, Lin CJ, Lai KA. Changes in coagulatory profile after orthopedic surgery. J Formos Med Assoc. 1995;94(9):541–547. PubMed

Solomon C, Hagl C, Rahe-Meyer N. Time course of haemostatic effects of fibrinogen concentrate administration in aortic surgery. Br J Anaesth. 2013;110(6):947–956. doi: 10.1093/bja/aes576. PubMed DOI PMC

Karlsson M, Ternstrom L, Hyllner M, Baghaei F, Flinck A, Skrtic S, et al. Prophylactic fibrinogen infusion reduces bleeding after coronary artery bypass surgery. A prospective randomised pilot study. Thromb Haemost. 2009;102(1):137–144. PubMed

Counts RB, Haisch C, Simon TL, Maxwell NG, Heimbach DM, Carrico CJ. Hemostasis in massively transfused trauma patients. Ann Surg. 1979;190(1):91–99. doi: 10.1097/00000658-197907000-00020. PubMed DOI PMC

Ciavarella D, Reed RL, Counts RB, Baron L, Pavlin E, Heimbach DM, et al. Clotting factor levels and the risk of diffuse microvascular bleeding in the massively transfused patient. Br J Haematol. 1987;67(3):365–368. doi: 10.1111/j.1365-2141.1987.tb02359.x. PubMed DOI

Reed RL, 2nd, Ciavarella D, Heimbach DM, Baron L, Pavlin E, Counts RB, et al. Prophylactic platelet administration during massive transfusion. A prospective, randomized, double-blind clinical study. Ann Surg. 1986;203(1):40–48. doi: 10.1097/00000658-198601000-00008. PubMed DOI PMC

Stansbury LG, Hess AS, Thompson K, Kramer B, Scalea TM, Hess JR. The clinical significance of platelet counts in the first 24 hours after severe injury. Transfusion. 2013;53(4):783–789. doi: 10.1111/j.1537-2995.2012.03828.x. PubMed DOI

Johansson PI, Stensballe J, Rosenberg I, Hilslov TL, Jorgensen L, Secher NH. Proactive administration of platelets and plasma for patients with a ruptured abdominal aortic aneurysm: evaluating a change in transfusion practice. Transfusion. 2007;47(4):593–598. doi: 10.1111/j.1537-2995.2007.01160.x. PubMed DOI

Schnuriger B, Inaba K, Abdelsayed GA, Lustenberger T, Eberle BM, Barmparas G, et al. The impact of platelets on the progression of traumatic intracranial hemorrhage. J Trauma. 2010;68(4):881–885. doi: 10.1097/TA.0b013e3181d3cc58. PubMed DOI

Joseph B, Pandit V, Meyer D, Butvidas L, Kulvatunyou N, Khalil M, et al. The significance of platelet count in traumatic brain injury patients on antiplatelet therapy. J Trauma Acute Care Surg. 2014;77(3):417–421. doi: 10.1097/TA.0000000000000372. PubMed DOI

Joseph B, Aziz H, Zangbar B, Kulvatunyou N, Pandit V, O’Keeffe T, et al. Acquired coagulopathy of traumatic brain injury defined by routine laboratory tests: which laboratory values matter? J Trauma Acute Care Surg. 2014;76(1):121–125. doi: 10.1097/TA.0b013e3182a9cc95. PubMed DOI

Anglin CO, Spence JS, Warner MA, Paliotta C, Harper C, Moore C, et al. Effects of platelet and plasma transfusion on outcome in traumatic brain injury patients with moderate bleeding diatheses. J Neurosurg. 2013;118(3):676–686. doi: 10.3171/2012.11.JNS12622. PubMed DOI

British Committee for Standards in Haematology, Blood Transfusion Task Force Guidelines for the use of platelet transfusions. Br J Haematol. 2003;122(1):10–23. doi: 10.1046/j.1365-2141.2003.04468.x. PubMed DOI

Liumbruno G, Bennardello F, Lattanzio A, Piccoli P, Rossetti G, Italian Society of Transfusion Medicine and Immunohaematology (SIMTI) Work Group Recommendations for the transfusion of plasma and platelets. Blood Transfus. 2009;7(2):132–150. PubMed PMC

Meissner A, Schlenke P. Massive bleeding and massive transfusion. Transfus Med Hemother. 2012;39(2):73–84. doi: 10.1159/000337250. PubMed DOI PMC

Hess JR, Lindell AL, Stansbury LG, Dutton RP, Scalea TM. The prevalence of abnormal results of conventional coagulation tests on admission to a trauma center. Transfusion. 2009;49(1):34–39. doi: 10.1111/j.1537-2995.2008.01944.x. PubMed DOI

Brown LM, Call MS, Margaret Knudson M, Cohen MJ, Trauma Outcomes Group. Holcomb JB, et al. A normal platelet count may not be enough: the impact of admission platelet count on mortality and transfusion in severely injured trauma patients. J Trauma. 2011;71(2 Suppl 3):S337–S342. doi: 10.1097/TA.0b013e318227f67c. PubMed DOI PMC

Floccard B, Rugeri L, Faure A, Saint Denis M, Boyle EM, Peguet O, et al. Early coagulopathy in trauma patients: an on-scene and hospital admission study. Injury. 2012;43(1):26–32. doi: 10.1016/j.injury.2010.11.003. PubMed DOI

Van Beek JG, Mushkudiani NA, Steyerberg EW, Butcher I, McHugh GS, Lu J, et al. Prognostic value of admission laboratory parameters in traumatic brain injury: results from the IMPACT study. J Neurotrauma. 2007;24(2):315–328. doi: 10.1089/neu.2006.0034. PubMed DOI

Nekludov M, Bellander BM, Blomback M, Wallen HN. Platelet dysfunction in patients with severe traumatic brain injury. J Neurotrauma. 2007;24(11):1699–1706. doi: 10.1089/neu.2007.0322. PubMed DOI

Wohlauer MV, Moore EE, Thomas S, Sauaia A, Evans E, Harr J, et al. Early platelet dysfunction: an unrecognized role in the acute coagulopathy of trauma. J Am Coll Surg. 2012;214(5):739–746. doi: 10.1016/j.jamcollsurg.2012.01.050. PubMed DOI PMC

Jacoby RC, Owings JT, Holmes J, Battistella FD, Gosselin RC, Paglieroni TG. Platelet activation and function after trauma. J Trauma. 2001;51(4):639–647. doi: 10.1097/00005373-200110000-00003. PubMed DOI

Kutcher ME, Redick BJ, McCreery RC, Crane IM, Greenberg MD, Cachola LM, et al. Characterization of platelet dysfunction after trauma. J Trauma Acute Care Surg. 2012;73(1):13–19. doi: 10.1097/TA.0b013e318256deab. PubMed DOI PMC

Bachelani AM, Bautz JT, Sperry JL, Corcos A, Zenati M, Billiar TR, et al. Assessment of platelet transfusion for reversal of aspirin after traumatic brain injury. Surgery. 2011;150(4):836–843. doi: 10.1016/j.surg.2011.07.059. PubMed DOI

Briggs A, Gates JD, Kaufman RM, Calahan C, Gormley WB, Havens JM. Platelet dysfunction and platelet transfusion in traumatic brain injury. J Surg Res. 2015;193(2):802–806. doi: 10.1016/j.jss.2014.08.016. PubMed DOI

Perkins JG, Cap AP, Spinella PC, Blackbourne LH, Grathwohl KW, Repine TB, et al. An evaluation of the impact of apheresis platelets used in the setting of massively transfused trauma patients. J Trauma. 2009;66(4 Suppl):S77–S84. doi: 10.1097/TA.0b013e31819d8936. PubMed DOI

Pidcoke HF, Aden JK, Mora AG, Borgman MA, Spinella PC, Dubick MA, et al. Ten-year analysis of transfusion in Operation Iraqi Freedom and Operation Enduring Freedom: increased plasma and platelet use correlates with improved survival. J Trauma Acute Care Surg. 2012;73(6 Suppl 5):S445–S452. doi: 10.1097/TA.0b013e3182754796. PubMed DOI

Gunter OL, Jr, Au BK, Isbell JM, Mowery NT, Young PP, Cotton BA. Optimizing outcomes in damage control resuscitation: identifying blood product ratios associated with improved survival. J Trauma. 2008;65(3):527–534. doi: 10.1097/TA.0b013e3181826ddf. PubMed DOI

Holcomb JB, Wade CE, Michalek JE, Chisholm GB, Zarzabal LA, Schreiber MA, et al. Increased plasma and platelet to red blood cell ratios improves outcome in 466 massively transfused civilian trauma patients. Ann Surg. 2008;248(3):447–458. PubMed

Zink KA, Sambasivan CN, Holcomb JB, Chisholm G, Schreiber MA. A high ratio of plasma and platelets to packed red blood cells in the first 6 hours of massive transfusion improves outcomes in a large multicenter study. Am J Surg. 2009;197(5):565–570. doi: 10.1016/j.amjsurg.2008.12.014. PubMed DOI

Inaba K, Lustenberger T, Rhee P, Holcomb JB, Blackbourne LH, Shulman I, et al. The impact of platelet transfusion in massively transfused trauma patients. J Am Coll Surg. 2010;211(5):573–579. doi: 10.1016/j.jamcollsurg.2010.06.392. PubMed DOI

Holcomb JB, Zarzabal LA, Michalek JE, Kozar RA, Spinella PC, Perkins JG, et al. Increased platelet:RBC ratios are associated with improved survival after massive transfusion. J Trauma. 2011;71(2 Suppl 3):S318–S328. doi: 10.1097/TA.0b013e318227edbb. PubMed DOI

Johansson PI, Oliveri RS, Ostrowski SR. Hemostatic resuscitation with plasma and platelets in trauma. J Emerg Trauma Shock. 2012;5(2):120–125. doi: 10.4103/0974-2700.96479. PubMed DOI PMC

Hallet J, Lauzier F, Mailloux O, Trottier V, Archambault P, Zarychanski R, et al. The use of higher platelet:RBC transfusion ratio in the acute phase of trauma resuscitation: a systematic review. Crit Care Med. 2013;41(12):2800–2811. doi: 10.1097/CCM.0b013e31829a6ecb. PubMed DOI

Brown JB, Cohen MJ, Minei JP, Maier RV, West MA, Billiar TR, et al. Debunking the survival bias myth: characterization of mortality during the initial 24 hours for patients requiring massive transfusion. J Trauma Acute Care Surg. 2012;73(2):358–364. doi: 10.1097/TA.0b013e31825889ba. PubMed DOI

Cotton BA, Dossett LA, Au BK, Nunez TC, Robertson AM, Young PP. Room for (performance) improvement: provider-related factors associated with poor outcomes in massive transfusion. J Trauma. 2009;67(5):1004–1012. doi: 10.1097/TA.0b013e3181bcb2a8. PubMed DOI

Holcomb JB, del Junco DJ, Fox EE, Wade CE, Cohen MJ, Schreiber MA, et al. The prospective, observational, multicenter, major trauma transfusion (PROMMTT) study: comparative effectiveness of a time-varying treatment with competing risks. JAMA Surg. 2013;148(2):127–136. doi: 10.1001/2013.jamasurg.387. PubMed DOI PMC

Rowell SE, Barbosa RR, Diggs BS, Schreiber MA, Trauma Outcomes G, Holcomb JB, et al. Effect of high product ratio massive transfusion on mortality in blunt and penetrating trauma patients. J Trauma. 2011;71(2 Suppl 3):S353–S357. doi: 10.1097/TA.0b013e318227ef53. PubMed DOI

Lustenberger T, Frischknecht A, Bruesch M, Keel MJ. Blood component ratios in massively transfused, blunt trauma patients--a time-dependent covariate analysis. J Trauma. 2011;71(5):1144–1150. doi: 10.1097/TA.0b013e318230e89b. PubMed DOI

Sharpe JP, Weinberg JA, Magnotti LJ, Maclennan PA, Schroeppel TJ, Fabian TC, et al. Accounting for differences in transfusion volume: are all massive transfusions created equal? J Trauma Acute Care Surg. 2012;72(6):1536–1540. doi: 10.1097/TA.0b013e318251e253. PubMed DOI

Rowell SE, Barbosa RR, Allison CE, Van PY, Schreiber MA, Trauma Outcomes G, et al. Gender-based differences in mortality in response to high product ratio massive transfusion. J Trauma. 2011;71(2 Suppl 3):S375–S379. doi: 10.1097/TA.0b013e318227f1aa. PubMed DOI

Sambasivan CN, Kunio NR, Nair PV, Zink KA, Michalek JE, Holcomb JB, et al. High ratios of plasma and platelets to packed red blood cells do not affect mortality in nonmassively transfused patients. J Trauma. 2011;71(2 Suppl 3):S329–S336. doi: 10.1097/TA.0b013e318227edd3. PubMed DOI

Dirks J, Jorgensen H, Jensen CH, Ostrowski SR, Johansson PI. Blood product ratio in acute traumatic coagulopathy--effect on mortality in a Scandinavian level 1 trauma centre. Scand J Trauma Resusc Emerg Med. 2010;18:65. doi: 10.1186/1757-7241-18-65. PubMed DOI PMC

Cap AP, Spinella PC, Borgman MA, Blackbourne LH, Perkins JG. Timing and location of blood product transfusion and outcomes in massively transfused combat casualties. J Trauma Acute Care Surg. 2012;73(2 Suppl 1):S89–S94. doi: 10.1097/TA.0b013e318260625a. PubMed DOI

Brasel KJ, Vercruysse G, Spinella PC, Wade CE, Blackbourne LH, Borgman MA, et al. The association of blood component use ratios with the survival of massively transfused trauma patients with and without severe brain injury. J Trauma. 2011;71(2 Suppl 3):S343–S352. PubMed

Johnson JL, Moore EE, Kashuk JL, Banerjee A, Cothren CC, Biffl WL, et al. Effect of blood products transfusion on the development of postinjury multiple organ failure. Arch Surg. 2010;145(10):973–977. doi: 10.1001/archsurg.2010.216. PubMed DOI

Howard BM, Kornblith LZ, Hendrickson CM, Redick BJ, Conroy AS, Nelson MF, et al. Differences in degree, differences in kind: characterizing lung injury in trauma. J Trauma Acute Care Surg. 2015;78(4):735–741. doi: 10.1097/TA.0000000000000583. PubMed DOI PMC

Inaba K, Branco BC, Rhee P, Blackbourne LH, Holcomb JB, Spinella PC, et al. Impact of the duration of platelet storage in critically ill trauma patients. J Trauma. 2011;71(6):1766–1773. doi: 10.1097/TA.0b013e31823bdbf9. PubMed DOI

McQuilten ZK, Crighton G, Engelbrecht S, Gotmaker R, Brunskill SJ, Murphy MF, et al. Transfusion interventions in critical bleeding requiring massive transfusion: a systematic review. Transfus Med Rev. 2015;29(2):127–137. doi: 10.1016/j.tmrv.2015.01.001. PubMed DOI

Sihler KC, Napolitano LM. Complications of massive transfusion. Chest. 2010;137(1):209–220. doi: 10.1378/chest.09-0252. PubMed DOI

De Robertis E, Kozek-Langenecker SA, Tufano R, Romano GM, Piazza O, Zito Marinosci G. Coagulopathy induced by acidosis, hypothermia and hypocalcaemia in severe bleeding. Minerva Anestesiol. 2015;81(1):65–75. PubMed

Ho KM, Leonard AD. Concentration-dependent effect of hypocalcaemia on mortality of patients with critical bleeding requiring massive transfusion: a cohort study. Anaesth Intensive Care. 2011;39(1):46–54. PubMed

Magnotti LJ, Bradburn EH, Webb DL, Berry SD, Fischer PE, Zarzaur BL, et al. Admission ionized calcium levels predict the need for multiple transfusions: a prospective study of 591 critically ill trauma patients. J Trauma. 2011;70(2):391–395. doi: 10.1097/TA.0b013e31820b5d98. PubMed DOI

Lier H, Krep H, Schroeder S, Stuber F. Preconditions of hemostasis in trauma: a review. The influence of acidosis, hypocalcemia, anemia, and hypothermia on functional hemostasis in trauma. J Trauma. 2008;65(4):951–960. doi: 10.1097/TA.0b013e318187e15b. PubMed DOI

Perkins JG, Cap AP, Weiss BM, Reid TJ, Bolan CD. Massive transfusion and nonsurgical hemostatic agents. Crit Care Med. 2008;36(7 Suppl):S325–S339. doi: 10.1097/CCM.0b013e31817e2ec5. PubMed DOI

Chechik O, Thein R, Fichman G, Haim A, Tov TB, Steinberg EL. The effect of clopidogrel and aspirin on blood loss in hip fracture surgery. Injury. 2011;42(11):1277–1282. doi: 10.1016/j.injury.2011.01.011. PubMed DOI

Kragh AM, Walden M, Apelqvist A, Wagner P, Atroshi I. Bleeding and first-year mortality following hip fracture surgery and preoperative use of low-dose acetylsalicylic acid: an observational cohort study. BMC Musculoskelet Disord. 2011;12:254. doi: 10.1186/1471-2474-12-254. PubMed DOI PMC

Nydick JA, Farrell ED, Marcantonio AJ, Hume EL, Marburger R, Ostrum RF. The use of clopidogrel (Plavix) in patients undergoing nonelective orthopaedic surgery. J Orthop Trauma. 2010;24(6):383–386. doi: 10.1097/BOT.0b013e3181c3f3d9. PubMed DOI

Thaler HW, Frisee F, Korninger C. Platelet aggregation inhibitors, platelet function testing, and blood loss in hip fracture surgery. J Trauma. 2010;69(5):1217–1220. doi: 10.1097/TA.0b013e3181f4ab6a. PubMed DOI

Collinge CA, Kelly KC, Little B, Weaver T, Schuster RD. The effects of clopidogrel (Plavix) and other oral anticoagulants on early hip fracture surgery. J Orthop Trauma. 2012;26(10):568–573. doi: 10.1097/BOT.0b013e318240d70f. PubMed DOI

Christy JM, Stawicki SP, Jarvis AM, Evans DC, Gerlach AT, Lindsey DE, et al. The impact of antiplatelet therapy on pelvic fracture outcomes. J Emerg Trauma Shock. 2011;4(1):64–69. doi: 10.4103/0974-2700.76841. PubMed DOI PMC

Wallace HC, Probe RA, Chaput CD, Patel KV. Operative treatment of hip fractures in patients on clopidogrel: a case-control study. Iowa Orthop J. 2012;32:95–99. PubMed PMC

Hossain FS, Rambani R, Ribee H, Koch L. Is discontinuation of clopidogrel necessary for intracapsular hip fracture surgery? Analysis of 102 hemiarthroplasties. J Orthop Traumatol. 2013;14(3):171–177. doi: 10.1007/s10195-013-0235-1. PubMed DOI PMC

Manaqibwala MI, Butler KA, Sagebien CA. Complications of hip fracture surgery on patients receiving clopidogrel therapy. Arch Orthop Trauma Surg. 2014;134(6):747–753. doi: 10.1007/s00402-014-1981-0. PubMed DOI

Ott MM, Eriksson E, Vanderkolk W, Christianson D, Davis A, Scholten D. Antiplatelet and anticoagulation therapies do not increase mortality in the absence of traumatic brain injury. J Trauma. 2010;68(3):560–563. doi: 10.1097/TA.0b013e3181ad6600. PubMed DOI

Feely MA, Mabry TM, Lohse CM, Sems SA, Mauck KF. Safety of clopidogrel in hip fracture surgery. Mayo Clin Proc. 2013;88(2):149–156. doi: 10.1016/j.mayocp.2012.11.007. PubMed DOI PMC

Wordsworth DR, Halsey T, Griffiths R, Parker MJ. Clopidogrel has no effect on mortality from hip fracture. Injury. 2013;44(6):743–746. doi: 10.1016/j.injury.2012.11.028. PubMed DOI

Siracuse JJ, Robich MP, Gautam S, Kasper EM, Moorman DW, Hauser CJ. Antiplatelet agents, warfarin, and epidemic intracranial hemorrhage. Surgery. 2010;148(4):724–729. doi: 10.1016/j.surg.2010.07.014. PubMed DOI

Jones K, Sharp C, Mangram AJ, Dunn EL. The effects of preinjury clopidogrel use on older trauma patients with head injuries. Am J Surg. 2006;192(6):743–745. doi: 10.1016/j.amjsurg.2006.08.037. PubMed DOI

Spektor S, Agus S, Merkin V, Constantini S. Low-dose aspirin prophylaxis and risk of intracranial hemorrhage in patients older than 60 years of age with mild or moderate head injury: a prospective study. J Neurosurg. 2003;99(4):661–665. doi: 10.3171/jns.2003.99.4.0661. PubMed DOI

Nishijima DK, Zehtabchi S, Berrong J, Legome E. Utility of platelet transfusion in adult patients with traumatic intracranial hemorrhage and preinjury antiplatelet use: a systematic review. J Trauma Acute Care Surg. 2012;72(6):1658–1663. doi: 10.1097/TA.0b013e318256dfc5. PubMed DOI PMC

Di Bartolomeo S, Marino M, Valent F, De Palma R. Effects of anticoagulant and antiplatelet drugs on the risk for hospital admission for traumatic injuries: a case-control and population-based study. J Trauma Acute Care Surg. 2014;76(2):437–442. doi: 10.1097/TA.0b013e3182aa80f9. PubMed DOI

Brewer ES, Reznikov B, Liberman RF, Baker RA, Rosenblatt MS, David CA, et al. Incidence and predictors of intracranial hemorrhage after minor head trauma in patients taking anticoagulant and antiplatelet medication. J Trauma. 2011;70(1):E1–E5. doi: 10.1097/TA.0b013e3181e5e286. PubMed DOI

Fabbri A, Servadei F, Marchesini G, Stein SC, Vandelli A. Predicting intracranial lesions by antiplatelet agents in subjects with mild head injury. J Neurol Neurosurg Psychiatry. 2010;81(11):1275–1279. doi: 10.1136/jnnp.2009.197467. PubMed DOI

Major J, Reed MJ. A retrospective review of patients with head injury with coexistent anticoagulant and antiplatelet use admitted from a UK emergency department. Emerg Med J. 2009;26(12):871–876. doi: 10.1136/emj.2008.068643. PubMed DOI

Tauber M, Koller H, Moroder P, Hitzl W, Resch H. Secondary intracranial hemorrhage after mild head injury in patients with low-dose acetylsalicylate acid prophylaxis. J Trauma. 2009;67(3):521–525. doi: 10.1097/TA.0b013e3181a7c184. PubMed DOI

Peck KA, Sise CB, Shackford SR, Sise MJ, Calvo RY, Sack DI, et al. Delayed intracranial hemorrhage after blunt trauma: are patients on preinjury anticoagulants and prescription antiplatelet agents at risk? J Trauma. 2011;71(6):1600–1604. doi: 10.1097/TA.0b013e31823b9ce1. PubMed DOI

Levine M, Wyler B, Lovecchio F, Roque P, Raja AS. Risk of intracranial injury after minor head trauma in patients with pre-injury use of clopidogrel. Am J Emerg Med. 2014;32(1):71–74. doi: 10.1016/j.ajem.2013.08.063. PubMed DOI

Mina AA, Knipfer JF, Park DY, Bair HA, Howells GA, Bendick PJ. Intracranial complications of preinjury anticoagulation in trauma patients with head injury. J Trauma. 2002;53(4):668–672. doi: 10.1097/00005373-200210000-00008. PubMed DOI

Ivascu FA, Howells GA, Junn FS, Bair HA, Bendick PJ, Janczyk RJ. Predictors of mortality in trauma patients with intracranial hemorrhage on preinjury aspirin or clopidogrel. J Trauma. 2008;65(4):785–788. doi: 10.1097/TA.0b013e3181848caa. PubMed DOI

Ohm C, Mina A, Howells G, Bair H, Bendick P. Effects of antiplatelet agents on outcomes for elderly patients with traumatic intracranial hemorrhage. J Trauma. 2005;58(3):518–522. doi: 10.1097/01.TA.0000151671.35280.8B. PubMed DOI

Fortuna GR, Mueller EW, James LE, Shutter LA, Butler KL. The impact of preinjury antiplatelet and anticoagulant pharmacotherapy on outcomes in elderly patients with hemorrhagic brain injury. Surgery. 2008;144(4):598–603. doi: 10.1016/j.surg.2008.06.009. PubMed DOI

Bonville DJ, Ata A, Jahraus CB, Arnold-Lloyd T, Salem L, Rosati C, et al. Impact of preinjury warfarin and antiplatelet agents on outcomes of trauma patients. Surgery. 2011;150(4):861–868. doi: 10.1016/j.surg.2011.07.070. PubMed DOI

Wong DK, Lurie F, Wong LL. The effects of clopidogrel on elderly traumatic brain injured patients. J Trauma. 2008;65(6):1303–1308. doi: 10.1097/TA.0b013e318185e234. PubMed DOI

Sansing LH, Messe SR, Cucchiara BL, Cohen SN, Lyden PD, Kasner SE, et al. Prior antiplatelet use does not affect hemorrhage growth or outcome after ICH. Neurology. 2009;72(16):1397–1402. doi: 10.1212/01.wnl.0000342709.31341.88. PubMed DOI PMC

Campbell PG, Yadla S, Sen AN, Jallo J, Jabbour P. Emergency reversal of clopidogrel in the setting of spontaneous intracerebral hemorrhage. World Neurosurg. 2011;76(1–2):100–104. doi: 10.1016/j.wneu.2011.02.010. PubMed DOI

Creutzfeldt CJ, Weinstein JR, Longstreth WT, Jr, Becker KJ, McPharlin TO, Tirschwell DL. Prior antiplatelet therapy, platelet infusion therapy, and outcome after intracerebral hemorrhage. J Stroke Cerebrovasc Dis. 2009;18(3):221–228. doi: 10.1016/j.jstrokecerebrovasdis.2008.10.007. PubMed DOI PMC

Suzuki Y, Kitahara T, Soma K, Konno S, Sato K, Suzuki S, et al. Impact of platelet transfusion on survival of patients with intracerebral hemorrhage after administration of anti-platelet agents at a tertiary emergency center. PLoS One. 2014;9(5):e97328. doi: 10.1371/journal.pone.0097328. PubMed DOI PMC

Thompson BB, Bejot Y, Caso V, Castillo J, Christensen H, Flaherty ML, et al. Prior antiplatelet therapy and outcome following intracerebral hemorrhage: a systematic review. Neurology. 2010;75(15):1333–1342. doi: 10.1212/WNL.0b013e3181f735e5. PubMed DOI PMC

Batchelor JS, Grayson A. A meta-analysis to determine the effect of preinjury antiplatelet agents on mortality in patients with blunt head trauma. Br J Neurosurg. 2013;27(1):12–18. doi: 10.3109/02688697.2012.705361. PubMed DOI

Joseph B, Sadoun M, Aziz H, Tang A, Wynne JL, Pandit V, et al. Repeat head computed tomography in anticoagulated traumatic brain injury patients: still warranted. Am Surg. 2014;80(1):43–47. PubMed

Fabbri A, Servadei F, Marchesini G, Bronzoni C, Montesi D, Arietta L, et al. Antiplatelet therapy and the outcome of subjects with intracranial injury: the Italian SIMEU study. Crit Care. 2013;17(2):R53. doi: 10.1186/cc12575. PubMed DOI PMC

Grandhi R, Harrison G, Voronovich Z, Bauer J, Chen SH, Nicholas D, et al. Preinjury warfarin, but not antiplatelet medications, increases mortality in elderly traumatic brain injury patients. J Trauma Acute Care Surg. 2015;78(3):614–621. doi: 10.1097/TA.0000000000000542. PubMed DOI

Nishijima DK, Shahlaie K, Sarkar K, Rudisill N, Holmes JF. Risk of unfavorable long-term outcome in older adults with traumatic intracranial hemorrhage and anticoagulant or antiplatelet use. Am J Emerg Med. 2013;31(8):1244–1247. doi: 10.1016/j.ajem.2013.04.035. PubMed DOI PMC

Joseph B, Pandit V, Aziz H, Kulvatunyou N, Hashmi A, Tang A, et al. Clinical outcomes in traumatic brain injury patients on preinjury clopidogrel: a prospective analysis. J Trauma Acute Care Surg. 2014;76(3):817–820. doi: 10.1097/TA.0b013e3182aafcf0. PubMed DOI

Joseph B, Aziz H, Pandit V, Kulvatunyou N, O’Keeffe T, Tang A, et al. Low-dose aspirin therapy is not a reason for repeating head computed tomographic scans in traumatic brain injury: a prospective study. J Surg Res. 2014;186(1):287–291. doi: 10.1016/j.jss.2013.08.009. PubMed DOI

Li X, Sun Z, Zhao W, Zhang J, Chen J, Li Y, et al. Effect of acetylsalicylic acid usage and platelet transfusion on postoperative hemorrhage and activities of daily living in patients with acute intracerebral hemorrhage. J Neurosurg. 2013;118(1):94–103. doi: 10.3171/2012.9.JNS112286. PubMed DOI

Naidech AM, Bassin SL, Bernstein RA, Batjer HH, Alberts MJ, Lindholm PF, et al. Reduced platelet activity is more common than reported anti-platelet medication use in patients with intracerebral hemorrhage. Neurocrit Care. 2009;11(3):307–310. doi: 10.1007/s12028-009-9219-7. PubMed DOI

Naidech AM, Jovanovic B, Liebling S, Garg RK, Bassin SL, Bendok BR, et al. Reduced platelet activity is associated with early clot growth and worse 3-month outcome after intracerebral hemorrhage. Stroke. 2009;40(7):2398–2401. doi: 10.1161/STROKEAHA.109.550939. PubMed DOI

Davis PK, Musunuru H, Walsh M, Cassady R, Yount R, Losiniecki A, et al. Platelet dysfunction is an early marker for traumatic brain injury-induced coagulopathy. Neurocrit Care. 2013;18(2):201–208. doi: 10.1007/s12028-012-9745-6. PubMed DOI

Hall R, Mazer CD. Antiplatelet drugs: a review of their pharmacology and management in the perioperative period. Anesth Analg. 2011;112(2):292–318. doi: 10.1213/ANE.0b013e318203f38d. PubMed DOI

Short S, Kram B, Taylor S, Cheng J, Ali K, Vasquez D. Effect of platelet inhibition on bleeding complications in trauma patients on preinjury clopidogrel. J Trauma Acute Care Surg. 2013;74(6):1419–1424. doi: 10.1097/TA.0b013e31828dac3e. PubMed DOI

Morgenstern LB, Hemphill JC, 3rd, Anderson C, Becker K, Broderick JP, Connolly ES, Jr, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2010;41(9):2108–2129. doi: 10.1161/STR.0b013e3181ec611b. PubMed DOI PMC

McMillian WD, Rogers FB. Management of prehospital antiplatelet and anticoagulant therapy in traumatic head injury: a review. J Trauma. 2009;66(3):942–950. doi: 10.1097/TA.0b013e3181978e7b. PubMed DOI

Ducruet AF, Hickman ZL, Zacharia BE, Grobelny BT, DeRosa PA, Landes E, et al. Impact of platelet transfusion on hematoma expansion in patients receiving antiplatelet agents before intracerebral hemorrhage. Neurol Res. 2010;32(7):706–710. doi: 10.1179/174313209X459129. PubMed DOI

Downey DM, Monson B, Butler KL, Fortuna GR, Jr, Saxe JM, Dolan JP, et al. Does platelet administration affect mortality in elderly head-injured patients taking antiplatelet medications? Am Surg. 2009;75(11):1100–1103. PubMed

Washington CW, Schuerer DJ, Grubb RL., Jr Platelet transfusion: an unnecessary risk for mild traumatic brain injury patients on antiplatelet therapy. J Trauma. 2011;71(2):358–363. doi: 10.1097/TA.0b013e318220ad7e. PubMed DOI

Batchelor JS, Grayson A. A meta-analysis to determine the effect on survival of platelet transfusions in patients with either spontaneous or traumatic antiplatelet medication-associated intracranial haemorrhage. BMJ Open. 2012;2(2):e000588. doi: 10.1136/bmjopen-2011-000588. PubMed DOI PMC

Naidech AM, Liebling SM, Rosenberg NF, Lindholm PF, Bernstein RA, Batjer HH, et al. Early platelet transfusion improves platelet activity and may improve outcomes after intracerebral hemorrhage. Neurocrit Care. 2012;16(1):82–87. doi: 10.1007/s12028-011-9619-3. PubMed DOI PMC

Vilahur G, Choi BG, Zafar MU, Viles-Gonzalez JF, Vorchheimer DA, Fuster V, et al. Normalization of platelet reactivity in clopidogrel-treated subjects. J Thromb Haemost. 2007;5(1):82–90. doi: 10.1111/j.1538-7836.2006.02245.x. PubMed DOI

Taylor G, Osinski D, Thevenin A, Devys JM. Is platelet transfusion efficient to restore platelet reactivity in patients who are responders to aspirin and/or clopidogrel before emergency surgery? J Trauma Acute Care Surg. 2013;74(5):1367–1369. doi: 10.1097/TA.0b013e31828cca61. PubMed DOI

Joseph B, Pandit V, Sadoun M, Larkins CG, Kulvatunyou N, Tang A, et al. A prospective evaluation of platelet function in patients on antiplatelet therapy with traumatic intracranial hemorrhage. J Trauma Acute Care Surg. 2013;75(6):990–994. doi: 10.1097/TA.0b013e3182a96591. PubMed DOI

Hansson EC, Shams Hakimi C, Astrom-Olsson K, Hesse C, Wallen H, Dellborg M, et al. Effects of ex vivo platelet supplementation on platelet aggregability in blood samples from patients treated with acetylsalicylic acid, clopidogrel, or ticagrelor. Br J Anaesth. 2014;112(3):570–575. doi: 10.1093/bja/aet339. PubMed DOI

de Gans K, de Haan RJ, Majoie CB, Koopman MM, Brand A, Dijkgraaf MG, et al. PATCH: platelet transfusion in cerebral haemorrhage: study protocol for a multicentre, randomised, controlled trial. BMC Neurol. 2010;10:19. doi: 10.1186/1471-2377-10-19. PubMed DOI PMC

Thiele T, Sumnig A, Hron G, Muller C, Althaus K, Schroeder HW, et al. Platelet transfusion for reversal of dual antiplatelet therapy in patients requiring urgent surgery: a pilot study. J Thromb Haemost. 2012;10(5):968–971. doi: 10.1111/j.1538-7836.2012.04699.x. PubMed DOI

Campbell PG, Sen A, Yadla S, Jabbour P, Jallo J. Emergency reversal of antiplatelet agents in patients presenting with an intracranial hemorrhage: a clinical review. World Neurosurg. 2010;74(2–3):279–285. doi: 10.1016/j.wneu.2010.05.030. PubMed DOI

Altman R, Scazziota A, DE Lourdes HM, Gonzalez C. Recombinant factor VIIa reverses the inhibitory effect of aspirin or aspirin plus clopidogrel on in vitro thrombin generation. J Thromb Haemost. 2006;4(9):2022–2027. doi: 10.1111/j.1538-7836.2006.02088.x. PubMed DOI

Skolnick BE, Shenouda M, Khutoryansky NM, Pusateri AE, Gabriel D, Carr ME. Reversal of clopidogrel-induced bleeding with rFVIIa in healthy subjects: a randomized, placebo-controlled, double-blind, exploratory study. Anesth Analg. 2011;113(4):703–710. doi: 10.1213/ANE.0b013e318228c690. PubMed DOI

Weber CF, Görlinger K, Byhahn C, Moritz A, Hanke AA, Zacharowski K, et al. Tranexamic acid partially improves platelet function in patients treated with dual antiplatelet therapy. Eur J Anaesthesiol. 2011;28(1):57–62. doi: 10.1097/EJA.0b013e32834050ab. PubMed DOI

Schöchl H, Posch A, Hanke A, Voelckel W, Solomon C. High-dose fibrinogen concentrate for haemostatic therapy of a major trauma patient with recent clopidogrel and aspirin intake. Scand J Clin Lab Invest. 2010;70(6):453–457. doi: 10.3109/00365513.2010.500396. PubMed DOI

Ruggeri ZM, Mannucci PM, Lombardi R, Federici AB, Zimmerman TS. Multimeric composition of factor VIII/von Willebrand factor following administration of DDAVP: implications for pathophysiology and therapy of von Willebrand’s disease subtypes. Blood. 1982;59(6):1272–1278. PubMed

Nichols WL, Hultin MB, James AH, Manco-Johnson MJ, Montgomery RR, Ortel TL, et al. von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA) Haemophilia. 2008;14(2):171–232. doi: 10.1111/j.1365-2516.2007.01643.x. PubMed DOI

Carless PA, Henry DA, Moxey AJ, O’Connell D, McClelland B, Henderson KM, et al. Desmopressin for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev. 2004;1:CD001884. PubMed PMC

Crescenzi G, Landoni G, Biondi-Zoccai G, Pappalardo F, Nuzzi M, Bignami E, et al. Desmopressin reduces transfusion needs after surgery: a meta-analysis of randomized clinical trials. Anesthesiology. 2008;109(6):1063–1076. doi: 10.1097/ALN.0b013e31818db18b. PubMed DOI

Steinlechner B, Zeidler P, Base E, Birkenberg B, Ankersmit HJ, Spannagl M, et al. Patients with severe aortic valve stenosis and impaired platelet function benefit from preoperative desmopressin infusion. Ann Thorac Surg. 2011;91(5):1420–1426. doi: 10.1016/j.athoracsur.2011.01.052. PubMed DOI

Weber CF, Dietrich W, Spannagl M, Hofstetter C, Jambor C. A point-of-care assessment of the effects of desmopressin on impaired platelet function using multiple electrode whole-blood aggregometry in patients after cardiac surgery. Anesth Analg. 2010;110(3):702–707. doi: 10.1213/ANE.0b013e3181c92a5c. PubMed DOI

Ozal E, Kuralay E, Bingol H, Cingoz F, Ceylan S, Tatar H. Does tranexamic acid reduce desmopressin-induced hyperfibrinolysis? J Thorac Cardiovasc Surg. 2002;123(3):539–543. doi: 10.1067/mtc.2002.117281. PubMed DOI

Reiter RA, Mayr F, Blazicek H, Galehr E, Jilma-Stohlawetz P, Domanovits H, et al. Desmopressin antagonizes the in vitro platelet dysfunction induced by GPIIb/IIIa inhibitors and aspirin. Blood. 2003;102(13):4594–4599. doi: 10.1182/blood-2002-11-3566. PubMed DOI

Leithauser B, Zielske D, Seyfert UT, Jung F. Effects of desmopressin on platelet membrane glycoproteins and platelet aggregation in volunteers on clopidogrel. Clin Hemorheol Microcirc. 2008;39(1–4):293–302. PubMed

Coppola A, Di Minno G. Desmopressin in inherited disorders of platelet function. Haemophilia. 2008;14(Suppl 1):31–39. PubMed

Laupacis A, Fergusson D. Drugs to minimize perioperative blood loss in cardiac surgery: meta-analyses using perioperative blood transfusion as the outcome. The International Study of Peri-operative Transfusion (ISPOT) Investigators. Anesth Analg. 1997;85(6):1258–1267. PubMed

Powner DJ, Hartwell EA, Hoots WK. Counteracting the effects of anticoagulants and antiplatelet agents during neurosurgical emergencies. Neurosurgery. 2005;57(5):823–831. doi: 10.1227/01.NEU.0000179915.74429.b2. PubMed DOI

Kapapa T, Rohrer S, Struve S, Petscher M, Konig R, Wirtz CR, et al. Desmopressin acetate in intracranial haemorrhage. Neurol Res Int. 2014;2014:298767. doi: 10.1155/2014/298767. PubMed DOI PMC

Naidech AM, Maas MB, Levasseur-Franklin KE, Liotta EM, Guth JC, Berman M, et al. Desmopressin improves platelet activity in acute intracerebral hemorrhage. Stroke. 2014;45(8):2451–2453. doi: 10.1161/STROKEAHA.114.006061. PubMed DOI PMC

Reiter R, Jilma-Stohlawetz P, Horvath M, Jilma B. Additive effects between platelet concentrates and desmopressin in antagonizing the platelet glycoprotein IIb/IIIa inhibitor eptifibatide. Transfusion. 2005;45(3):420–426. doi: 10.1111/j.1537-2995.2005.04021.x. PubMed DOI

Kim D, O’Leary M, Nguyen A, Kaji A, Bricker S, Neville A, et al. The effect of platelet and desmopressin administration on early radiographic progression of traumatic intracranial hemorrhage. J Neurotrauma. 2015;32:1815–21. doi: 10.1089/neu.2014.3728. PubMed DOI

Levine M, Swenson S, McCormick T, Henderson SO, Thomas SH, Markland FS. Reversal of thienopyridine-induced platelet dysfunction following desmopressin administration. J Med Toxicol. 2013;9(2):139–143. doi: 10.1007/s13181-012-0275-6. PubMed DOI PMC

Teng R, Mitchell PD, Butler K. The effect of desmopressin on bleeding time and platelet aggregation in healthy volunteers administered ticagrelor. J Clin Pharm Ther. 2014;39(2):186–191. doi: 10.1111/jcpt.12130. PubMed DOI

Singleton T, Kruse-Jarres R, Leissinger C. Emergency department care for patients with hemophilia and von Willebrand disease. J Emerg Med. 2010;39(2):158–165. doi: 10.1016/j.jemermed.2007.12.024. PubMed DOI

Ng KF, Cheung CW, Lee Y, Leung SW. Low-dose desmopressin improves hypothermia-induced impairment of primary haemostasis in healthy volunteers. Anaesthesia. 2011;66(11):999–1005. doi: 10.1111/j.1365-2044.2011.06821.x. PubMed DOI

Hanke AA, Dellweg C, Kienbaum P, Weber CF, Görlinger K, Rahe-Meyer N. Effects of desmopressin on platelet function under conditions of hypothermia and acidosis: an in vitro study using multiple electrode aggregometry*. Anaesthesia. 2010;65(7):688–691. doi: 10.1111/j.1365-2044.2010.06367.x. PubMed DOI

Quinlan DJ, Eikelboom JW, Weitz JI. Four-factor prothrombin complex concentrate for urgent reversal of vitamin K antagonists in patients with major bleeding. Circulation. 2013;128(11):1179–1181. PubMed

Sarode R, Milling TJ, Jr, Refaai MA, Mangione A, Schneider A, Durn BL, et al. Efficacy and safety of a 4-factor prothrombin complex concentrate in patients on vitamin K antagonists presenting with major bleeding: a randomized, plasma-controlled, phase IIIb study. Circulation. 2013;128(11):1234–1243. PubMed PMC

Goldstein JN, Refaai MA, Milling TJ, Jr, Lewis B, Goldberg-Alberts R, Hug BA, et al. Four-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open-label, non-inferiority, randomised trial. Lancet. 2015;385(9982):2077–2087. doi: 10.1016/S0140-6736(14)61685-8. PubMed DOI PMC

Huttner HB, Schellinger PD, Hartmann M, Kohrmann M, Juettler E, Wikner J, et al. Hematoma growth and outcome in treated neurocritical care patients with intracerebral hemorrhage related to oral anticoagulant therapy: comparison of acute treatment strategies using vitamin K, fresh frozen plasma, and prothrombin complex concentrates. Stroke. 2006;37(6):1465–1470. doi: 10.1161/01.STR.0000221786.81354.d6. PubMed DOI

Edavettal M, Rogers A, Rogers F, Horst M, Leng W. Prothrombin complex concentrate accelerates international normalized ratio reversal and diminishes the extension of intracranial hemorrhage in geriatric trauma patients. Am Surg. 2014;80(4):372–376. PubMed

Baglin TP, Keeling DM, Watson HG. Guidelines on oral anticoagulation (warfarin): third edition--2005 update. Br J Haematol. 2006;132(3):277–285. doi: 10.1111/j.1365-2141.2005.05856.x. PubMed DOI

Grottke O, van Ryn J, Spronk HM, Rossaint R. Prothrombin complex concentrates and a specific antidote to dabigatran are effective ex-vivo in reversing the effects of dabigatran in an anticoagulation/liver trauma experimental model. Crit Care. 2014;18(1):R27. doi: 10.1186/cc13717. PubMed DOI PMC

Tanaka KA, Mazzeffi M, Durila M. Role of prothrombin complex concentrate in perioperative coagulation therapy. J Intensive Care. 2014;2(1):60. doi: 10.1186/s40560-014-0060-5. PubMed DOI PMC

Lee FM, Chan AK, Lau KK, Chan HH. Reversal of new, factor-specific oral anticoagulants by rFVIIa, prothrombin complex concentrate and activated prothrombin complex concentrate: a review of animal and human studies. Thromb Res. 2014;133(5):705–713. doi: 10.1016/j.thromres.2014.01.031. PubMed DOI

Babilonia K, Trujillo T. The role of prothrombin complex concentrates in reversal of target specific anticoagulants. Thromb J. 2014;12:8. doi: 10.1186/1477-9560-12-8. PubMed DOI PMC

Baumann Kreuziger LM, Keenan JC, Morton CT, Dries DJ. Management of the bleeding patient receiving new oral anticoagulants: a role for prothrombin complex concentrates. Biomed Res Int. 2014;2014:583794. doi: 10.1155/2014/583794. PubMed DOI PMC

Chapman SA, Irwin ED, Beal AL, Kulinski NM, Hutson KE, Thorson MA. Prothrombin complex concentrate versus standard therapies for INR reversal in trauma patients receiving warfarin. Ann Pharmacother. 2011;45(7–8):869–875. doi: 10.1345/aph.1P605. PubMed DOI

Schöchl H, Forster L, Woidke R, Solomon C, Voelckel W. Use of rotation thromboelastometry (ROTEM) to achieve successful treatment of polytrauma with fibrinogen concentrate and prothrombin complex concentrate. Anaesthesia. 2010;65(2):199–203. doi: 10.1111/j.1365-2044.2009.06188.x. PubMed DOI

Rizoli SB, Scarpelini S, Callum J, Nascimento B, Mann KG, Pinto R, et al. Clotting factor deficiency in early trauma-associated coagulopathy. J Trauma. 2011;71(5 Suppl 1):S427–S434. doi: 10.1097/TA.0b013e318232e5ab. PubMed DOI PMC

Safaoui MN, Aazami R, Hotz H, Wilson MT, Margulies DR. A promising new alternative for the rapid reversal of warfarin coagulopathy in traumatic intracranial hemorrhage. Am J Surg. 2009;197(6):785–790. doi: 10.1016/j.amjsurg.2008.04.003. PubMed DOI

Grassetto A, De Nardin M, Ganzerla B, Geremia M, Saggioro D, Serafini E, et al. ROTEM(R)-guided coagulation factor concentrate therapy in trauma: 2-year experience in Venice. Italy. Crit Care. 2012;16(3):428. PubMed PMC

Sarode R, Matevosyan K, Bhagat R, Rutherford C, Madden C, Beshay JE. Rapid warfarin reversal: a 3-factor prothrombin complex concentrate and recombinant factor VIIa cocktail for intracerebral hemorrhage. J Neurosurg. 2012;116(3):491–497. doi: 10.3171/2011.11.JNS11836. PubMed DOI

Philippou H, Adami A, Lane DA, MacGregor IR, Tuddenham EG, Lowe GD, et al. High purity factor IX and prothrombin complex concentrate (PCC): pharmacokinetics and evidence that factor IXa is the thrombogenic trigger in PCC. Thromb Haemost. 1996;76(1):23–28. PubMed

Kessler CM. Urgent reversal of warfarin with prothrombin complex concentrate: where are the evidence-based data? J Thromb Haemost. 2006;4(5):963–966. doi: 10.1111/j.1538-7836.2006.01944.x. PubMed DOI

Bruce D, Nokes TJ. Prothrombin complex concentrate (Beriplex P/N) in severe bleeding: experience in a large tertiary hospital. Crit Care. 2008;12(4):R105. doi: 10.1186/cc6987. PubMed DOI PMC

Huynh TK, Costello JL, Rebuck JA. Optimizing the dose of three-factor prothrombin complex concentrate in traumatic brain injury patients on warfarin therapy. Pharmacotherapy. 2014;34(3):260–264. doi: 10.1002/phar.1384. PubMed DOI

Kerebel D, Joly LM, Honnart D, Schmidt J, Galanaud D, Negrier C, et al. A French multicenter randomised trial comparing two dose-regimens of prothrombin complex concentrates in urgent anticoagulation reversal. Crit Care. 2013;17(1):R4. doi: 10.1186/cc11923. PubMed DOI PMC

Majeed A, Eelde A, Agren A, Schulman S, Holmstrom M. Thromboembolic safety and efficacy of prothrombin complex concentrates in the emergency reversal of warfarin coagulopathy. Thromb Res. 2012;129(2):146–151. doi: 10.1016/j.thromres.2011.07.024. PubMed DOI

Sorensen B, Spahn DR, Innerhofer P, Spannagl M, Rossaint R. Clinical review: prothrombin complex concentrates--evaluation of safety and thrombogenicity. Crit Care. 2011;15(1):201. doi: 10.1186/cc9311. PubMed DOI PMC

Pabinger I, Tiede A, Kalina U, Knaub S, Germann R, Ostermann H. Impact of infusion speed on the safety and effectiveness of prothrombin complex concentrate: a prospective clinical trial of emergency anticoagulation reversal. Ann Hematol. 2010;89(3):309–316. doi: 10.1007/s00277-009-0830-7. PubMed DOI

Dentali F, Marchesi C, Pierfranceschi MG, Crowther M, Garcia D, Hylek E, et al. Safety of prothrombin complex concentrates for rapid anticoagulation reversal of vitamin K antagonists. A meta-analysis. Thromb Haemost. 2011;106(3):429–38. doi: 10.1160/TH11-01-0052. PubMed DOI

Park MS, Owen BA, Ballinger BA, Sarr MG, Schiller HJ, Zietlow SP, et al. Quantification of hypercoagulable state after blunt trauma: microparticle and thrombin generation are increased relative to injury severity, while standard markers are not. Surgery. 2012;151(6):831–836. doi: 10.1016/j.surg.2011.12.022. PubMed DOI PMC

Grottke O, Braunschweig T, Spronk HM, Esch S, Rieg AD, van Oerle R, et al. Increasing concentrations of prothrombin complex concentrate induce disseminated intravascular coagulation in a pig model of coagulopathy with blunt liver injury. Blood. 2011;118(7):1943–1951. doi: 10.1182/blood-2011-03-343046. PubMed DOI

Schochl H, Schlimp CJ, Maegele M. Tranexamic acid, fibrinogen concentrate, and prothrombin complex concentrate: data to support prehospital use? Shock. 2014;41(Suppl 1):44–46. doi: 10.1097/SHK.0000000000000093. PubMed DOI

Turpie AG, Kreutz R, Llau J, Norrving B, Haas S. Management consensus guidance for the use of rivaroxaban--an oral, direct factor Xa inhibitor. Thromb Haemost. 2012;108(5):876–886. doi: 10.1160/TH12-03-0209. PubMed DOI

Levy JH, Key NS, Azran MS. Novel oral anticoagulants: implications in the perioperative setting. Anesthesiology. 2010;113(3):726–745. PubMed

Asmis LM, Alberio L, Angelillo-Scherrer A, Korte W, Mendez A, Reber G, et al. Rivaroxaban: quantification by anti-FXa assay and influence on coagulation tests: a study in 9 Swiss laboratories. Thromb Res. 2012;129(4):492–498. doi: 10.1016/j.thromres.2011.06.031. PubMed DOI

Spahn DR, Korte W. Novel oral anticoagulants: new challenges for anesthesiologists in bleeding patients. Anesthesiology. 2012;116(1):9–11. doi: 10.1097/ALN.0b013e318238c070. PubMed DOI

Godier A, Miclot A, Le Bonniec B, Durand M, Fischer AM, Emmerich J, et al. Evaluation of prothrombin complex concentrate and recombinant activated factor VII to reverse rivaroxaban in a rabbit model. Anesthesiology. 2012;116(1):94–102. doi: 10.1097/ALN.0b013e318238c036. PubMed DOI

Truumees E, Gaudu T, Dieterichs C, Geck M, Stokes J. Epidural hematoma and intraoperative hemorrhage in a spine trauma patient on Pradaxa (dabigatran) Spine (Phila Pa 1976) 2012;37:E863–E865. doi: 10.1097/BRS.0b013e31824ee320. PubMed DOI

Perzborn E, Heitmeier S, Laux V, Buchmuller A. Reversal of rivaroxaban-induced anticoagulation with prothrombin complex concentrate, activated prothrombin complex concentrate and recombinant activated factor VII in vitro. Thromb Res. 2014;133(4):671–681. doi: 10.1016/j.thromres.2014.01.017. PubMed DOI

Levi M, Moore KT, Castillejos CF, Kubitza D, Berkowitz SD, Goldhaber SZ, et al. Comparison of three-factor and four-factor prothrombin complex concentrates regarding reversal of the anticoagulant effects of rivaroxaban in healthy volunteers. J Thromb Haemost. 2014;12(9):1428–1436. doi: 10.1111/jth.12599. PubMed DOI

Herrmann R, Thom J, Wood A, Phillips M, Muhammad S, Baker R. Thrombin generation using the calibrated automated thrombinoscope to assess reversibility of dabigatran and rivaroxaban. Thromb Haemost. 2014;111(5):989–995. doi: 10.1160/TH13-07-0607. PubMed DOI

Lindahl TL, Wallstedt M, Gustafsson KM, Persson E, Hillarp A. More efficient reversal of dabigatran inhibition of coagulation by activated prothrombin complex concentrate or recombinant factor VIIa than by four-factor prothrombin complex concentrate. Thromb Res. 2015;135(3):544–547. doi: 10.1016/j.thromres.2014.12.019. PubMed DOI

Solbeck S, Meyer MA, Johansson PI, Meyer AS, Cotton BA, Stensballe J, et al. Monitoring of dabigatran anticoagulation and its reversal in vitro by thrombelastography. Int J Cardiol. 2014;176(3):794–799. doi: 10.1016/j.ijcard.2014.07.084. PubMed DOI

Eerenberg ES, Kamphuisen PW, Sijpkens MK, Meijers JC, Buller HR, Levi M. Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects. Circulation. 2011;124(14):1573–1579. doi: 10.1161/CIRCULATIONAHA.111.029017. PubMed DOI

Khoo TL, Weatherburn C, Kershaw G, Reddel CJ, Curnow J, Dunkley S. The use of FEIBA(R) in the correction of coagulation abnormalities induced by dabigatran. Int J Lab Hematol. 2013;35(2):222–224. doi: 10.1111/ijlh.12005. PubMed DOI

Marlu R, Hodaj E, Paris A, Albaladejo P, Crackowski JL, Pernod G. Effect of non-specific reversal agents on anticoagulant activity of dabigatran and rivaroxaban: a randomised crossover ex vivo study in healthy volunteers. Thromb Haemost. 2012;108(2):217–224. doi: 10.1160/TH12-03-0179. PubMed DOI

Honickel M, Treutler S, van Ryn J, Tillmann S, Rossaint R, Grottke O. Reversal of dabigatran anticoagulation ex vivo: Porcine study comparing prothrombin complex concentrates and idarucizumab. Thromb Haemost. 2015;113(4):728–740. doi: 10.1160/TH14-08-0712. PubMed DOI

Hoffman M, Volovyk Z, Monroe DM. Reversal of dabigatran effects in models of thrombin generation and hemostasis by factor VIIa and prothrombin complex concentrate. Anesthesiology. 2015;122(2):353–362. doi: 10.1097/ALN.0000000000000540. PubMed DOI

Herzog E, Kaspereit F, Krege W, Mueller-Cohrs J, Doerr B, Niebl P, et al. Correlation of coagulation markers and 4 F-PCC-mediated reversal of rivaroxaban in a rabbit model of acute bleeding. Thromb Res. 2015;135(3):554–560. doi: 10.1016/j.thromres.2015.01.007. PubMed DOI

Pernod G, Albaladejo P, Godier A, Samama CM, Susen S, Gruel Y, et al. Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors: proposals of the working group on perioperative haemostasis (GIHP) - March 2013. Arch Cardiovasc Dis. 2013;106(6-7):382–393. doi: 10.1016/j.acvd.2013.04.009. PubMed DOI

Dias JD, Norem K, Doorneweerd DD, Thurer RL, Popovsky MA, Omert LA. Use of thromboelastography (TEG) for detection of new oral anticoagulants. Arch Pathol Lab Med. 2015;139(5):665–673. doi: 10.5858/arpa.2014-0170-OA. PubMed DOI

Glund S, Stangier J, Schmohl M, Gansser D, Norris S, van Ryn J, et al. Safety, tolerability, and efficacy of idarucizumab for the reversal of the anticoagulant effect of dabigatran in healthy male volunteers: a randomised, placebo-controlled, double-blind phase 1 trial. Lancet. 2015;386(9994):680–690. doi: 10.1016/S0140-6736(15)60732-2. PubMed DOI

Pollack CV, Jr., Reilly PA, Eikelboom J, Glund S, Verhamme P, Bernstein RA, Dubiel R, Huisman MV, Hylek EM, Kamphuisen PW et al: Idarucizumab for dabigatran reversal. N Engl J Med. 2015;373(6):511-20. PubMed

Lowe MP, Collins J, Yehia M, Eaddy N. Reversal of dabigatran with haemodialysis in a patient requiring decompression for cord compression from an epidural abscess. Nephrology (Carlton) 2013;18(8):580–582. doi: 10.1111/nep.12100. PubMed DOI

Parra MW, Zucker L, Johnson ES, Gullett D, Avila C, Wichner ZA, et al. Dabigatran bleed risk with closed head injuries: are we prepared? J Neurosurg. 2013;119(3):760–765. doi: 10.3171/2013.3.JNS12503. PubMed DOI

Clave A, Fazilleau F, Dumser D, Lacroix J. Efficacy of tranexamic acid on blood loss after primary cementless total hip replacement with rivaroxaban thromboprophylaxis: a case-control study in 70 patients. Orthop Traumatol Surg Res. 2012;98(5):484–490. doi: 10.1016/j.otsr.2011.12.005. PubMed DOI

Siegal DM, Curnutte JT, Connolly SJ, Lu G, Conley PB, Wiens BL, et al. Andexanet alfa for the reversal of factor Xa inhibitor activity. N Engl J Med. 2015;373(25):2413–2424. doi: 10.1056/NEJMoa1510991. PubMed DOI

Lu G, DeGuzman FR, Hollenbach SJ, Karbarz MJ, Abe K, Lee G, et al. A specific antidote for reversal of anticoagulation by direct and indirect inhibitors of coagulation factor Xa. Nat Med. 2013;19(4):446–451. doi: 10.1038/nm.3102. PubMed DOI

Schiele F, van Ryn J, Canada K, Newsome C, Sepulveda E, Park J, et al. A specific antidote for dabigatran: functional and structural characterization. Blood. 2013;121(18):3554–3562. doi: 10.1182/blood-2012-11-468207. PubMed DOI

Hoffman M. A cell-based model of coagulation and the role of factor VIIa. Blood Rev. 2003;17(Suppl 1):S1–S5. doi: 10.1016/S0268-960X(03)90000-2. PubMed DOI

Hoffman M, Monroe DM., 3rd A cell-based model of hemostasis. Thromb Haemost. 2001;85(6):958–965. PubMed

Luna GK, Maier RV, Pavlin EG, Anardi D, Copass MK, Oreskovich MR. Incidence and effect of hypothermia in seriously injured patients. J Trauma. 1987;27(9):1014–1018. doi: 10.1097/00005373-198709000-00010. PubMed DOI

Knudson MM, Cohen MJ, Reidy R, Jaeger S, Bacchetti P, Jin C, et al. Trauma, transfusions, and use of recombinant factor VIIa: a multicenter case registry report of 380 patients from the Western Trauma Association. J Am Coll Surg. 2011;212(1):87–95. doi: 10.1016/j.jamcollsurg.2010.08.020. PubMed DOI

Mitra B, Cameron PA, Parr MJ, Phillips L. Recombinant factor VIIa in trauma patients with the ‘triad of death’. Injury. 2012;43(9):1409–1414. doi: 10.1016/j.injury.2011.01.033. PubMed DOI

Zatta A, McQuilten Z, Kandane-Rathnayake R, Isbister J, Dunkley S, McNeil J, et al. The Australian and New Zealand Haemostasis Registry: ten years of data on off-licence use of recombinant activated factor VII. Blood Transfus. 2015;13(1):86–99. PubMed PMC

Vivien B, Langeron O, Morell E, Devilliers C, Carli PA, Coriat P, et al. Early hypocalcemia in severe trauma. Crit Care Med. 2005;33(9):1946–1952. doi: 10.1097/01.CCM.0000171840.01892.36. PubMed DOI

James MF, Roche AM. Dose-response relationship between plasma ionized calcium concentration and thrombelastography. J Cardiothorac Vasc Anesth. 2004;18(5):581–586. doi: 10.1053/j.jvca.2004.07.016. PubMed DOI

Martinowitz U, Kenet G, Segal E, Luboshitz J, Lubetsky A, Ingerslev J, et al. Recombinant activated factor VII for adjunctive hemorrhage control in trauma. J Trauma. 2001;51(3):431–438. doi: 10.1097/00005373-200109000-00002. PubMed DOI

Martinowitz U, Michaelson M. Guidelines for the use of recombinant activated factor VII (rFVIIa) in uncontrolled bleeding: a report by the Israeli Multidisciplinary rFVIIa Task Force. J Thromb Haemost. 2005;3(4):640–648. doi: 10.1111/j.1538-7836.2005.01203.x. PubMed DOI

Harrison TD, Laskosky J, Jazaeri O, Pasquale MD, Cipolle M. “Low-dose” recombinant activated factor VII results in less blood and blood product use in traumatic hemorrhage. J Trauma. 2005;59(1):150–154. doi: 10.1097/01.TA.0000171470.39742.8E. PubMed DOI

Dutton RP, McCunn M, Hyder M, D’Angelo M, O’Connor J, Hess JR, et al. Factor VIIa for correction of traumatic coagulopathy. J Trauma. 2004;57(4):709–718. doi: 10.1097/01.TA.0000140646.66852.AB. PubMed DOI

Boffard KD, Riou B, Warren B, Choong PI, Rizoli S, Rossaint R, et al. Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials. J Trauma. 2005;59(1):8–15. doi: 10.1097/01.TA.0000171453.37949.B7. PubMed DOI

Nascimento B, Lin Y, Callum J, Reis M, Pinto R, Rizoli S. Recombinant factor VIIa is associated with an improved 24-hour survival without an improvement in inpatient survival in massively transfused civilian trauma patients. Clinics (Sao Paulo) 2011;66(1):101–106. doi: 10.1590/S1807-59322011000100018. PubMed DOI PMC

McQuay N, Jr, Cipolla J, Franges EZ, Thompson GE. The use of recombinant activated factor VIIa in coagulopathic traumatic brain injuries requiring emergent craniotomy: is it beneficial? J Neurosurg. 2009;111(4):666–671. doi: 10.3171/2009.4.JNS081611. PubMed DOI

Morse BC, Dente CJ, Hodgman EI, Shaz BH, Nicholas JM, Wyrzykowski AD, et al. The effects of protocolized use of recombinant factor VIIa within a massive transfusion protocol in a civilian level I trauma center. Am Surg. 2011;77(8):1043–1049. PubMed

Hauser CJ, Boffard K, Dutton R, Bernard GR, Croce MA, Holcomb JB, et al. Results of the CONTROL trial: efficacy and safety of recombinant activated Factor VII in the management of refractory traumatic hemorrhage. J Trauma. 2010;69(3):489–500. doi: 10.1097/TA.0b013e3181edf36e. PubMed DOI

Wafaisade A, Lefering R, Maegele M, Helm P, Braun M, Paffrath T, et al. Recombinant factor VIIa for the treatment of exsanguinating trauma patients: a matched-pair analysis from the Trauma Registry of the German Society for Trauma Surgery. Unfallchirurg. 2013;116(6):524–530. doi: 10.1007/s00113-011-2146-z. PubMed DOI

Yao D, Li Y, Wang J, Yu W, Li N, Li J. Effects of recombinant activated factor VIIa on abdominal trauma patients. Blood Coagul Fibrinolysis. 2014;25(1):33–38. doi: 10.1097/MBC.0000000000000021. PubMed DOI

DeLoughery EP, Lenfesty B, DeLoughery TG. A retrospective case control study of recombinant factor VIIa in patients with intracranial haemorrhage caused by trauma. Br J Haematol. 2011;152(5):667–669. doi: 10.1111/j.1365-2141.2010.08437.x. PubMed DOI

Perel P, Roberts I, Shakur H, Thinkhamrop B, Phuenpathom N, Yutthakasemsunt S. Haemostatic drugs for traumatic brain injury. Cochrane Database Syst Rev. 2010;1:CD007877. PubMed PMC

DeLoughery EP, Lenfesty B, DeLoughery TG. The use of recombinant factor VIIa in warfarin patients with traumatic brain injury: a retrospective case-control study. Blood Coagul Fibrinolysis. 2013;24(3):317–320. doi: 10.1097/MBC.0b013e32835cc16b. PubMed DOI

Vincent JL, Rossaint R, Riou B, Ozier Y, Zideman D, Spahn DR. Recommendations on the use of recombinant activated factor VII as an adjunctive treatment for massive bleeding--a European perspective. Crit Care. 2006;10(4):R120. doi: 10.1186/cc5026. PubMed DOI PMC

Klitgaard T, Tabanera y Palacios R, Boffard KD, Iau PT, Warren B, Rizoli S, et al. Pharmacokinetics of recombinant activated factor VII in trauma patients with severe bleeding. Crit Care. 2006;10(4):R104. doi: 10.1186/cc4977. PubMed DOI PMC

Bain J, Lewis D, Bernard A, Hatton K, Reda H, Flynn J. Implementation of an off-label recombinant factor VIIa protocol for patients with critical bleeding at an academic medical center. J Thromb Thrombolysis. 2014;38(4):447–452. doi: 10.1007/s11239-014-1107-0. PubMed DOI

Yuan Q, Wu X, Du ZY, Sun YR, Yu J, Li ZQ, et al. Low-dose recombinant factor VIIa for reversing coagulopathy in patients with isolated traumatic brain injury. J Crit Care. 2015;30(1):116–120. doi: 10.1016/j.jcrc.2014.07.009. PubMed DOI

O’Connell KA, Wood JJ, Wise RP, Lozier JN, Braun MM. Thromboembolic adverse events after use of recombinant human coagulation factor VIIa. JAMA. 2006;295(3):293–298. doi: 10.1001/jama.295.3.293. PubMed DOI

rFVIIa; eptacog alfa; NovoSeven. EPAR - Product Information: http://www.emea.europa.eu/. Accessed 30 Jan 2015.

Dutton RP, Parr M, Tortella BJ, Champion HR, Bernard GR, Boffard K, et al. Recombinant activated factor VII safety in trauma patients: results from the CONTROL trial. J Trauma. 2011;71(1):12–19. doi: 10.1097/TA.0b013e31821a42cf. PubMed DOI

Bucklin MH, Acquisto NM, Nelson C. The effects of recombinant activated factor VII dose on the incidence of thromboembolic events in patients with coagulopathic bleeding. Thromb Res. 2014;133(5):768–771. doi: 10.1016/j.thromres.2014.02.026. PubMed DOI

Geerts WH, Code KI, Jay RM, Chen E, Szalai JP. A prospective study of venous thromboembolism after major trauma. N Engl J Med. 1994;331(24):1601–1606. doi: 10.1056/NEJM199412153312401. PubMed DOI

Velmahos GC, Kern J, Chan L, Oder D, Murray JA, Shekelle P. Prevention of venous thromboembolism after injury. Evid Rep Technol Assess (Summ) 2000;22:1–3. PubMed PMC

Alhazzani W, Lim W, Jaeschke RZ, Murad MH, Cade J, Cook DJ. Heparin thromboprophylaxis in medical-surgical critically ill patients: a systematic review and meta-analysis of randomized trials. Crit Care Med. 2013;41(9):2088–2098. doi: 10.1097/CCM.0b013e31828cf104. PubMed DOI

Lim W, Meade M, Lauzier F, Zarychanski R, Mehta S, Lamontagne F, et al. Failure of anticoagulant thromboprophylaxis: risk factors in medical-surgical critically ill patients*. Crit Care Med. 2015;43(2):401–410. doi: 10.1097/CCM.0000000000000713. PubMed DOI

Lubenow N, Hinz P, Thomaschewski S, Lietz T, Vogler M, Ladwig A, et al. The severity of trauma determines the immune response to PF4/heparin and the frequency of heparin-induced thrombocytopenia. Blood. 2010;115(9):1797–1803. doi: 10.1182/blood-2009-07-231506. PubMed DOI

Shen X, Dutcher SK, Palmer J, Liu X, Kiptanui Z, Khokhar B, Al-Jawadi MH, Zhu Y, Zuckerman IH. A systematic review of the benefits and risks of anticoagulation following traumatic brain injury. J Head Trauma Rehabil. 2015;30(4):E29–37. doi: 10.1097/HTR.0000000000000077. PubMed DOI PMC

Ho KM, Chavan S, Pilcher D. Omission of early thromboprophylaxis and mortality in critically ill patients: a multicenter registry study. Chest. 2011;140(6):1436–1446. doi: 10.1378/chest.11-1444. PubMed DOI

Jacobsen AF, Skjeldestad FE, Sandset PM. Ante- and postnatal risk factors of venous thrombosis: a hospital-based case-control study. J Thromb Haemost. 2008;6(6):905–912. doi: 10.1111/j.1538-7836.2008.02961.x. PubMed DOI

CLOTS (Clots in legs or stockings after stroke) Trials Collaboration. Dennis M, Sandercock P, Reid J, Graham C, Forbes J, et al. Effectiveness of intermittent pneumatic compression in reduction of risk of deep vein thrombosis in patients who have had a stroke (CLOTS 3): a multicentre randomised controlled trial. Lancet. 2013;382(9891):516–524. doi: 10.1016/S0140-6736(13)61050-8. PubMed DOI

Shafi S, Barnes SA, Rayan N, Kudyakov R, Foreman M, Cryer HG, et al. Compliance with recommended care at trauma centers: association with patient outcomes. J Am Coll Surg. 2014;219(2):189–198. doi: 10.1016/j.jamcollsurg.2014.04.005. PubMed DOI

Shafi S, Rayan N, Barnes S, Fleming N, Gentilello LM, Ballard D. Moving from “optimal resources” to “optimal care” at trauma centers. J Trauma Acute Care Surg. 2012;72(4):870–877. doi: 10.1097/TA.0b013e3182463e20. PubMed DOI

Rice TW, Morris S, Tortella BJ, Wheeler AP, Christensen MC. Deviations from evidence-based clinical management guidelines increase mortality in critically injured trauma patients*. Crit Care Med. 2012;40(3):778–786. doi: 10.1097/CCM.0b013e318236f168. PubMed DOI

Barleben A, Jafari F, Rose J, Jr, Dolich M, Malinoski D, Lekawa M, et al. Implementation of a cost-saving algorithm for pelvic radiographs in blunt trauma patients. J Trauma. 2011;71(3):582–584. doi: 10.1097/TA.0b013e31822b771e. PubMed DOI

Haynes AB, Weiser TG, Berry WR, Lipsitz SR, Breizat AH, Dellinger EP, et al. A surgical safety checklist to reduce morbidity and mortality in a global population. N Engl J Med. 2009;360(5):491–499. doi: 10.1056/NEJMsa0810119. PubMed DOI

Gillespie BM, Chaboyer W, Thalib L, John M, Fairweather N, Slater K. Effect of using a safety checklist on patient complications after surgery: a systematic review and meta-analysis. Anesthesiology. 2014;120(6):1380–1389. doi: 10.1097/ALN.0000000000000232. PubMed DOI

Levy M, Rhodes A, Phillips G, Townsend S, Schorr C, Beale R, et al. Surviving Sepsis Campaign: association between performance metrics and outcomes in a 7.5-year study. Intensive Care Med. 2014;40(11):1623–1633. doi: 10.1007/s00134-014-3496-0. PubMed DOI

HMGB-1 as a predictor of major bleeding requiring activation of a massive transfusion protocol in severe trauma

Shock Index for Early Detection of Low Plasma Fibrinogen in Trauma: A Prospective Observational Cohort Pilot Study

The European guideline on management of major bleeding and coagulopathy following trauma: fifth edition